A	O
central	O
role	O
for	O
a	O
single	B-DNA
c-Myb	I-DNA
binding	I-DNA
site	I-DNA
in	O
a	O
thymic	B-DNA
locus	I-DNA
control	I-DNA
region	I-DNA
.	O

Locus	B-DNA
control	I-DNA
regions	I-DNA
(	O
LCRs	B-DNA
)	O
are	O
powerful	O
assemblies	O
of	O
cis	B-DNA
elements	I-DNA
that	O
organize	O
the	O
actions	O
of	O
cell-type-specific	B-protein
trans-acting	I-protein
factors	I-protein
.	O

A	O
2.3-kb	B-protein
LCR	I-protein
in	O
the	O
human	B-DNA
adenosine	I-DNA
deaminase	I-DNA
(	I-DNA
ADA	I-DNA
)	I-DNA
gene	I-DNA
first	I-DNA
intron	I-DNA
,	O
which	O
controls	O
expression	O
in	O
thymocytes	B-cell_type
,	O
is	O
composed	O
of	O
a	O
200-bp	B-DNA
enhancer	I-DNA
domain	I-DNA
and	O
extended	O
flanking	O
sequences	O
that	O
facilitate	O
activation	O
from	O
within	O
chromatin	B-DNA
.	O

Prior	O
analyses	O
have	O
demonstrated	O
that	O
the	O
enhancer	B-DNA
contains	O
a	O
28-bp	B-DNA
core	I-DNA
region	I-DNA
and	O
local	O
adjacent	O
augmentative	O
cis	B-DNA
elements	I-DNA
.	O

We	O
now	O
show	O
that	O
the	O
core	O
contains	O
a	O
single	O
critical	O
c-Myb	B-DNA
binding	I-DNA
site	I-DNA
.	O

In	O
both	O
transiently	B-cell_line
cotransfected	I-cell_line
human	I-cell_line
cells	I-cell_line
and	O
stable	O
chromatin-integrated	B-cell_line
yeast	I-cell_line
cells	I-cell_line
,	O
c-Myb	B-protein
strongly	O
transactivated	B-DNA
reporter	I-DNA
constructs	I-DNA
that	O
contained	O
polymerized	B-DNA
core	I-DNA
sequences	I-DNA
.	O

c-Myb	B-protein
protein	I-protein
was	O
strongly	O
evident	O
in	O
T	B-cell_type
lymphoblasts	I-cell_type
in	O
which	O
the	O
enhancer	B-DNA
was	O
active	O
and	O
was	O
localized	O
within	O
discrete	O
nuclear	O
structures	O
.	O

Fetal	O
murine	O
thymus	O
exhibited	O
a	O
striking	O
concordance	O
of	O
endogenous	O
c-myb	B-DNA
expression	O
with	O
that	O
of	O
mouse	B-DNA
ADA	I-DNA
and	O
human	B-DNA
ADA	I-DNA
LCR	I-DNA
-directed	O
transgene	O
expression	O
.	O

Point	O
mutation	O
of	O
the	O
c-Myb	B-DNA
site	I-DNA
within	O
the	O
intact	O
2.3-kb	B-protein
LCR	I-protein
severely	O
attenuated	O
enhancer	O
activity	O
in	O
transfections	O
and	O
LCR	B-DNA
activity	O
in	O
transgenic	B-cell_line
thymocytes	I-cell_line
.	O

Within	O
the	O
context	O
of	O
a	O
complex	B-DNA
enhancer	I-DNA
and	O
LCR	B-DNA
,	O
c-Myb	B-protein
can	O
act	O
as	O
an	O
organizer	O
of	O
thymocyte-specific	B-DNA
gene	I-DNA
expression	O
via	O
a	O
single	O
binding	O
site	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGy	NULL
,	NULL
Oct.	NULL
1995	NULL
,	NULL
p.	NULL
5707-5715	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

10	NULL
A	NULL
Central	NULL
Role	NULL
for	NULL
a	NULL
Single	NULL
c-Myb	NULL
Binding	NULL
Site	NULL
in	NULL
a	NULL
Thymic	NULL
Locus	NULL
Control	NULL
Region	NULL
KEVIN	NULL
C.	NULL
ESS	NULL
,	NULL
``	NULL
TERESA	NULL
L.	NULL
WHITAKER	NULL
,	NULL
``	NULL
GREGORY	NULL
J	NULL
.	NULL

COST	NULL
,	NULL
``	NULL
DAVID	NULL
P.	NULL
WITTE	NULL
,	NULL
``	NULL
JOHN	NULL
J.	NULL
HUTTON	NULL
,	NULL
!	NULL

AND	NULL
BRUCE	NULL
J	NULL
.	NULL

ARONOW	NULL
!	NULL

*	NULL
Department	NULL
of	NULL
Pediatrics	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
``	NULL
Division	NULL
of	NULL
Basic	NULL
Science	NULL
Research	NULL
,	NULL
Program	NULL
in	NULL
Developmental	NULL
Biology	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
Medical	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Cincinnati	NULL
,	NULL
Cincinnati	NULL
,	NULL
Ohio	NULL
45229	NULL
Received	NULL
4	NULL
April	NULL
1995/Returned	NULL
for	NULL
modification	NULL
19	NULL
May	NULL
1995/Accepted	NULL
23	NULL
June	NULL
1995	NULL
Locus	NULL
control	NULL
regions	NULL
(	NULL
LCRs	NULL
)	NULL
are	NULL
powerful	NULL
assemblies	NULL
of	NULL
cis	NULL
elements	NULL
that	NULL
organize	NULL
the	NULL
actions	NULL
of	NULL
cell-type-specific	NULL
trans-acting	NULL
factors	NULL
.	NULL

A	NULL
2.3-kb	NULL
LCR	NULL
in	NULL
the	NULL
human	NULL
adenosine	NULL
deaminase	NULL
(	NULL
ADA	NULL
)	NULL
gene	NULL
first	NULL
intron	NULL
,	NULL
which	NULL
controls	NULL
expression	NULL
in	NULL
thymocytes	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
200-bp	NULL
enhancer	NULL
domain	NULL
and	NULL
extended	NULL
flanking	NULL
sequences	NULL
that	NULL
facilitate	NULL
activation	NULL
from	NULL
within	NULL
chromatin	NULL
.	NULL

Prior	NULL
analyses	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
contains	NULL
a	NULL
28-bp	NULL
core	NULL
region	NULL
and	NULL
local	NULL
adjacent	NULL
augmentative	NULL
cis	NULL
elements	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
the	NULL
core	NULL
contains	NULL
a	NULL
single	NULL
critical	NULL
c-Myb	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
both	NULL
transiently	NULL
cotransfected	NULL
human	NULL
cells	NULL
and	NULL
stable	NULL
chromatin-integrated	NULL
yeast	NULL
cells	NULL
,	NULL
c-Myb	NULL
strongly	NULL
transactivated	NULL
reporter	NULL
constructs	NULL
that	NULL
contained	NULL
polymerized	NULL
core	NULL
sequences	NULL
.	NULL

c-Myb	NULL
protein	NULL
was	NULL
strongly	NULL
evident	NULL
in	NULL
T	NULL
lymphoblasts	NULL
in	NULL
which	NULL
the	NULL
enhancer	NULL
was	NULL
active	NULL
and	NULL
was	NULL
localized	NULL
within	NULL
discrete	NULL
nuclear	NULL
structures	NULL
.	NULL

Fetal	NULL
murine	NULL
thymus	NULL
exhibited	NULL
a	NULL
striking	NULL
concordance	NULL
of	NULL
endogenous	NULL
c-myh	NULL
expression	NULL
with	NULL
that	NULL
of	NULL
mouse	NULL
ADA	NULL
and	NULL
human	NULL
ADA	NULL
LCR-directed	NULL
transgene	NULL
expression	NULL
.	NULL

Point	NULL
mutation	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
within	NULL
the	NULL
intact	NULL
2.3-kb	NULL
LCR	NULL
severely	NULL
attenuated	NULL
enhancer	NULL
activity	NULL
in	NULL
transfections	NULL
and	NULL
LCR	NULL
activity	NULL
in	NULL
transgenic	NULL
thymocytes	NULL
.	NULL

Within	NULL
the	NULL
context	NULL
of	NULL
a	NULL
complex	NULL
enhancer	NULL
and	NULL
LCR	NULL
,	NULL
c-Myb	NULL
can	NULL
act	NULL
as	NULL
an	NULL
organizer	NULL
of	NULL
thymocyte-specific	NULL
gene	NULL
expression	NULL
via	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
.	NULL

Cellular	NULL
differentiation	NULL
requires	NULL
developmental	NULL
gene	NULL
regulation	NULL
that	NULL
results	NULL
from	NULL
the	NULL
combined	NULL
actions	NULL
of	NULL
multiple	NULL
transcriptional	NULL
factors	NULL
acting	NULL
on	NULL
clustered	NULL
cis	NULL
elements	NULL
within	NULL
enhancers	NULL
and	NULL
promoters	NULL
.	NULL

The	NULL
most	NULL
powerful	NULL
clusters	NULL
of	NULL
cis	NULL
elements	NULL
are	NULL
locus	NULL
control	NULL
regions	NULL
(	NULL
LCRs	NULL
)	NULL
that	NULL
dictate	NULL
chromatin	NULL
structure	NULL
transitions	NULL
and	NULL
factor	NULL
accessibility	NULL
and	NULL
organize	NULL
multiple	NULL
transcription	NULL
factor	NULL
interactions	NULL
(	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
30	NULL
)	NULL
.	NULL

LCRs	NULL
seem	NULL
generally	NULL
composed	NULL
of	NULL
classical	NULL
enhancer	NULL
segments	NULL
and	NULL
additional	NULL
sequences	NULL
required	NULL
for	NULL
activation	NULL
in	NULL
chromatin	NULL
.	NULL

Individual	NULL
factor	NULL
binding	NULL
sites	NULL
of	NULL
enhancers	NULL
frequently	NULL
appear	NULL
to	NULL
be	NULL
dispensable	NULL
in	NULL
transfection	NULL
assays	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
view	NULL
of	NULL
enhancers	NULL
as	NULL
being	NULL
composed	NULL
of	NULL
a	NULL
series	NULL
of	NULL
redundant	NULL
binding	NULL
sites	NULL
with	NULL
overlapping	NULL
functions	NULL
.	NULL

Few	NULL
studies	NULL
in	NULL
transgenic	NULL
mice	NULL
have	NULL
addressed	NULL
the	NULL
role	NULL
of	NULL
individual	NULL
enhancer	NULL
elements	NULL
within	NULL
the	NULL
context	NULL
of	NULL
intact	NULL
LCRs	NULL
.	NULL

However	NULL
,	NULL
available	NULL
data	NULL
suggest	NULL
that	NULL
individual	NULL
sites	NULL
tend	NULL
not	NULL
to	NULL
be	NULL
required	NULL
for	NULL
position-independent	NULL
transgene	NULL
expression	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
have	NULL
limited	NULL
insight	NULL
into	NULL
the	NULL
process	NULL
by	NULL
which	NULL
individual	NULL
cis-regulatory	NULL
elements	NULL
within	NULL
LCRs	NULL
participate	NULL
in	NULL
chromatin	NULL
activation	NULL
and	NULL
the	NULL
determination	NULL
of	NULL
transcription	NULL
rates	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
.	NULL

LCRs	NULL
appear	NULL
to	NULL
become	NULL
active	NULL
in	NULL
a	NULL
stepwise	NULL
fashion	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
20	NULL
)	NULL
.	NULL

A	NULL
likely	NULL
early	NULL
event	NULL
is	NULL
a	NULL
structural	NULL
transition	NULL
of	NULL
chromatin	NULL
to	NULL
an	NULL
accessible	NULL
state	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
distinct	NULL
chromatin	NULL
structure	NULL
that	NULL
is	NULL
hypersensitive	NULL
to	NULL
DNase	NULL
I	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
this	NULL
process	NULL
,	NULL
it	NULL
is	NULL
a	NULL
striking	NULL
feature	NULL
of	NULL
cells	NULL
in	NULL
which	NULL
an	NULL
LCR	NULL
is	NULL
active	NULL
that	NULL
there	NULL
is	NULL
a	NULL
remarkable	NULL
cell-to-cell	NULL
uniformity	NULL
of	NULL
mRNA	NULL
production	NULL
.	NULL

This	NULL
is	NULL
evident	NULL
for	NULL
both	NULL
endogenous	NULL
genes	NULL
and	NULL
transgenes	NULL
on	NULL
a	NULL
per-copy	NULL
basis	NULL
.	NULL

Most	NULL
presently	NULL
characterized	NULL
LCRs	NULL
are	NULL
from	NULL
genes	NULL
that	NULL
express	NULL
prodigious	NULL
levels	NULL
of	NULL
mRNA	NULL
in	NULL
target	NULL
cells	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
-globin	NULL
,	NULL
immunoglobulin	NULL
heavy-chain	NULL
,	NULL
and	NULL
serum	NULL
albumin	NULL
genes	NULL
)	NULL
.	NULL

The	NULL
human	NULL
adenosine	NULL
deaminase	NULL
(	NULL
ADA	NULL
)	NULL
gene	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
513	NULL
)	NULL
559-4865	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
513	NULL
)	NULL
559-4317	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
bruce.aronow	NULL
@	NULL
uc.edu	NULL
.	NULL

5707	NULL
2.3-kb	NULL
thymic	NULL
LCR	NULL
,	NULL
differs	NULL
from	NULL
the	NULL
above-cited	NULL
examples	NULL
in	NULL
that	NULL
it	NULL
directs	NULL
considerably	NULL
lower	NULL
levels	NULL
of	NULL
mRNA	NULL
.	NULL

ADA	NULL
is	NULL
expressed	NULL
in	NULL
cortical	NULL
thymocytes	NULL
,	NULL
in	NULL
which	NULL
T-cell	NULL
receptor	NULL
re-arrangement	NULL
,	NULL
positive	NULL
selection	NULL
,	NULL
and	NULL
negative	NULL
selection	NULL
occur	NULL
.	NULL

The	NULL
vast	NULL
majority	NULL
of	NULL
cortical	NULL
T	NULL
cells	NULL
normally	NULL
do	NULL
not	NULL
mature	NULL
and	NULL
undergo	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
28	NULL
)	NULL
.	NULL

When	NULL
thymocyte	NULL
DNA	NULL
is	NULL
degraded	NULL
during	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
34	NULL
)	NULL
,	NULL
ADA	NULL
is	NULL
essential	NULL
for	NULL
purine	NULL
catabolism	NULL
,	NULL
as	NULL
its	NULL
genetic	NULL
absence	NULL
causes	NULL
a	NULL
failure	NULL
to	NULL
develop	NULL
cortical	NULL
thymocytes	NULL
.	NULL

Deletional	NULL
analyses	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
have	NULL
identified	NULL
a	NULL
classical	NULL
enhancer	NULL
that	NULL
encompasses	NULL
a	NULL
200-bp	NULL
domain	NULL
corresponding	NULL
to	NULL
a	NULL
thymocyte-specific	NULL
DNase	NULL
I-hypersensitive	NULL
region	NULL
centered	NULL
within	NULL
the	NULL
2.3-kb	NULL
intronic	NULL
thymic	NULL
LCR	NULL
.	NULL

Flanking	NULL
the	NULL
200-bp	NULL
enhancer	NULL
region	NULL
are	NULL
extended	NULL
segments	NULL
required	NULL
for	NULL
insertion	NULL
site-independent	NULL
and	NULL
copy	NULL
number-proportional	NULL
transgene	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Using	NULL
transiently	NULL
transfected	NULL
T	NULL
cells	NULL
,	NULL
deletional	NULL
analyses	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
200-bp	NULL
enhancer	NULL
region	NULL
is	NULL
hierarchically	NULL
structured	NULL
,	NULL
composed	NULL
of	NULL
a	NULL
28-bp	NULL
core	NULL
and	NULL
augmentative	NULL
flanking	NULL
elements	NULL
.	NULL

We	NULL
now	NULL
report	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
demonstrating	NULL
that	NULL
c-Myb	NULL
protein	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
within	NULL
the	NULL
core	NULL
enhancer	NULL
element	NULL
,	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
within	NULL
multiple	NULL
cell	NULL
types	NULL
,	NULL
initiates	NULL
transcriptional	NULL
activity	NULL
from	NULL
within	NULL
yeast	NULL
chromatin	NULL
,	NULL
and	NULL
is	NULL
present	NULL
in	NULL
thymocytic	NULL
T	NULL
cells	NULL
within	NULL
discrete	NULL
subnuclear	NULL
structures	NULL
.	NULL

Within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
LCR	NULL
,	NULL
point	NULL
mutation	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
strongly	NULL
disables	NULL
enhancer	NULL
activity	NULL
in	NULL
transiently	NULL
transfected	NULL
T	NULL
cells	NULL
.	NULL

Thymocytes	NULL
in	NULL
five	NULL
of	NULL
six	NULL
transgenic	NULL
lines	NULL
with	NULL
the	NULL
c-Myb	NULL
site	NULL
mutation	NULL
exhibited	NULL
very	NULL
poor	NULL
LCR	NULL
function	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
cortical	NULL
thymocyte	NULL
gene	NULL
expression	NULL
and	NULL
suggest	NULL
that	NULL
complex	NULL
regulatory	NULL
domains	NULL
such	NULL
as	NULL
LCRs	NULL
can	NULL
be	NULL
organized	NULL
around	NULL
single	NULL
sites	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
c-Myb	NULL
protein	NULL
.	NULL

A	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-truncated	NULL
c-Myb	NULL
fusion	NULL
protein	NULL
(	NULL
GSTmyb-0.7	NULL
)	NULL
was	NULL
made	NULL
to	NULL
avoid	NULL
protein	NULL
degradation	NULL
observed	NULL
in	NULL
bac-	NULL
5708	NULL
ESS	NULL
ET	NULL
AL	NULL
.	NULL

teria	NULL
that	NULL
contained	NULL
full-length	NULL
c-Myb	NULL
expression	NULL
vectors	NULL
.	NULL

To	NULL
do	NULL
this	NULL
,	NULL
a	NULL
721-bp	NULL
Ncol-Hincll	NULL
fragment	NULL
of	NULL
pMbm-1	NULL
(	NULL
37	NULL
)	NULL
encoding	NULL
the	NULL
c-Myb	NULL
DNA	NULL
binding	NULL
domain	NULL
was	NULL
subcloned	NULL
into	NULL
pGEX4T-2	NULL
(	NULL
Pharmacia	NULL
)	NULL
to	NULL
produce	NULL
pGSTmyb-0.7	NULL
in	NULL
host	NULL
Escherichia	NULL
coli	NULL
DHS	NULL
«	NULL
cells	NULL
(	NULL
Gibco/BRL	NULL
)	NULL
.	NULL

Midlog	NULL
cultures	NULL
were	NULL
induced	NULL
with	NULL
0.1	NULL
mM	NULL
isopropylthiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
for	NULL
3	NULL
h	NULL
and	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
c-Myb	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
retain	NULL
the	NULL
specificity	NULL
of	NULL
full-length	NULL
c-Myb	NULL
for	NULL
target	NULL
sequences	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Two	NULL
microliters	NULL
of	NULL
eluate	NULL
from	NULL
glutathi-one-Sepharose	NULL
representing	NULL
approximately	NULL
50	NULL
ng	NULL
of	NULL
fusion	NULL
protein	NULL
(	NULL
as	NULL
judged	NULL
from	NULL
silver	NULL
stain	NULL
intensity	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
labeled	NULL
and	NULL
unlabeled	NULL
oligonucleotides	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
25	NULL
pl	NULL
that	NULL
contained	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
4	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
electrophoresed	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
dye	NULL
on	NULL
a	NULL
5	NULL
%	NULL
acrylamide-0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
gel	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transient	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Molt-4	NULL
,	NULL
CCRF-CEM	NULL
,	NULL
and	NULL
Raji	NULL
lymphoid	NULL
cells	NULL
,	NULL
culture	NULL
conditions	NULL
,	NULL
DEAFE-dextran	NULL
transfections	NULL
,	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
,	NULL
as	NULL
have	NULL
ADA	NULL
core	NULL
element	NULL
reporter	NULL
constructs	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Electroporation	NULL
of	NULL
Raji	NULL
cells	NULL
was	NULL
done	NULL
essentially	NULL
by	NULL
the	NULL
procedure	NULL
of	NULL
Bhaumik	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
for	NULL
each	NULL
transfection	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
exponential	NULL
growth	NULL
were	NULL
washed	NULL
with	NULL
1X	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
PBS	NULL
containing	NULL
7.5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
added	NULL
to	NULL
0.4-cm	NULL
Bio-Rad	NULL
cuvettes	NULL
containing	NULL
transfection	NULL
DNA	NULL
,	NULL
briefly	NULL
mixed	NULL
,	NULL
and	NULL
electroporated	NULL
at	NULL
260	NULL
V	NULL
and	NULL
960	NULL
wF	NULL
in	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
.	NULL

Cells	NULL
were	NULL
immediately	NULL
plated	NULL
in	NULL
12	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin-streptomycin	NULL
(	NULL
Gibco/BRL	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
45	NULL
to	NULL
48	NULL
h	NULL
later	NULL
for	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

Yeast	NULL
strains	NULL
,	NULL
reporter	NULL
genes	NULL
,	NULL
and	NULL
expression	NULL
plasmids	NULL
.	NULL

Saccharomyces	NULL
cerevi-sige	NULL
W303-1A	NULL
(	NULL
MATacan1-100	NULL
his3-11,15	NULL
leu2-3,112	NULL
trpl-1	NULL
ura3-1	NULL
ade2-1	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
host	NULL
for	NULL
reporter	NULL
constructions	NULL
and	NULL
subsequently	NULL
transformed	NULL
with	NULL
expression	NULL
plasmids	NULL
.	NULL

Yeast	NULL
reporter	NULL
plasmids	NULL
that	NULL
integrated	NULL
into	NULL
the	NULL
URA3	NULL
locus	NULL
were	NULL
made	NULL
with	NULL
ADA	NULL
core	NULL
sequences	NULL
by	NULL
inserting	NULL
corresponding	NULL
oligonucleotides	NULL
immediately	NULL
upstream	NULL
of	NULL
a	NULL
GAL	NULL
]	NULL
TATA	NULL
yeast	NULL
promoter	NULL
and	NULL
lacZ	NULL
reporter	NULL
gene	NULL
designated	NULL
pLR1deltaldelta2p	NULL
(	NULL
36	NULL
)	NULL
.	NULL

RC	NULL
,	NULL
R1	NULL
,	NULL
and	NULL
R7	NULL
oligonucleotides	NULL
were	NULL
ligation	NULL
multimerized	NULL
into	NULL
the	NULL
Xhol	NULL
site	NULL
of	NULL
this	NULL
plasmid	NULL
,	NULL
which	NULL
was	NULL
then	NULL
linearized	NULL
at	NULL
Stul	NULL
and	NULL
transformed	NULL
into	NULL
strain	NULL
W303-1A	NULL
by	NULL
the	NULL
lithium	NULL
acetate	NULL
proto-col.	NULL
For	NULL
each	NULL
clone	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
structure	NULL
was	NULL
confirmed	NULL
by	NULL
Southern	NULL
blot	NULL
hybridization	NULL
.	NULL

Integrant	NULL
clones	NULL
were	NULL
grown	NULL
overnight	NULL
in	NULL
YEPD	NULL
medium	NULL
and	NULL
transformed	NULL
with	NULL
yeast	NULL
vectors	NULL
that	NULL
expressed	NULL
either	NULL
wild-type	NULL
c-Myb	NULL
(	NULL
CCC	NULL
)	NULL
,	NULL
a	NULL
C-terminal	NULL
truncation	NULL
(	NULL
CCd	NULL
)	NULL
,	NULL
or	NULL
an	NULL
N-terminal	NULL
truncation	NULL
(	NULL
dCC	NULL
)	NULL
.	NULL

c-Myb	NULL
trun-cations	NULL
correspond	NULL
closely	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
v-Myb	NULL
.	NULL

Control	NULL
yeast	NULL
reporter	NULL
strains	NULL
containing	NULL
known	NULL
c-Myb-responsive	NULL
mim-1A-LacZ	NULL
reporter	NULL
genes	NULL
YSW5	NULL
(	NULL
+	NULL
)	NULL
(	NULL
wild	NULL
type	NULL
)	NULL
and	NULL
YSMS5	NULL
(	NULL
+	NULL
)	NULL
(	NULL
myb	NULL
site	NULL
mutated	NULL
)	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Rui-Hong	NULL
Chen	NULL
and	NULL
Joseph	NULL
Lipsick	NULL
.	NULL

All	NULL
expression	NULL
vectors	NULL
were	NULL
provided	NULL
by	NULL
Rui-Hong	NULL
Chen	NULL
and	NULL
minimally	NULL
contained	NULL
c-Myb	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
2	NULL
wm	NULL
replication	NULL
origin	NULL
and	NULL
TRP	NULL
]	NULL
selectable	NULL
marker	NULL
.	NULL

Transformants	NULL
were	NULL
screened	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
with	NULL
the	NULL
5-bromo-4-chloro-3-indolyl-B-p-galactopyranoside	NULL
(	NULL
X-Gal	NULL
)	NULL
filter	NULL
assay	NULL
as	NULL
described	NULL
by	NULL
Chen	NULL
and	NULL
Lipsick	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Three	NULL
representative	NULL
clones	NULL
per	NULL
construct	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
quantitative	NULL
determination	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
using	NULL
liquid	NULL
cultures	NULL
grown	NULL
to	NULL
an	NULL
optical	NULL
density	NULL
at	NULL
600	NULL
nm	NULL
of	NULL
1.0	NULL
and	NULL
the	NULL
substrate	NULL
orthonitrophenyl-B-p-galactopyranoside	NULL
.	NULL

B-Galactosidase	NULL
units	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Miller	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Assays	NULL
were	NULL
done	NULL
in	NULL
duplicate	NULL
,	NULL
with	NULL
three	NULL
independent	NULL
clones	NULL
assayed	NULL
per	NULL
construct	NULL
.	NULL

Reproducibility	NULL
was	NULL
within	NULL
20	NULL
%	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
and	NULL
in	NULL
situ	NULL
hybridizations	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
purified	NULL
by	NULL
using	NULL
Tri-Reagent	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
analysis	NULL
,	NULL
a	NULL
0.6-kb	NULL
HindIII-EcoRI	NULL
fragment	NULL
from	NULL
pRSVmyb	NULL
(	NULL
10	NULL
)	NULL
was	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
method	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
.	NULL

For	NULL
e-myb	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
the	NULL
same	NULL
0.6-kb	NULL
fragment	NULL
subcloned	NULL
in	NULL
pBluescript	NULL
was	NULL
linearized	NULL
with	NULL
HindIII	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
a-*°SJUTP	NULL
.	NULL

Mouse	NULL
ADA	NULL
and	NULL
CAT	NULL
in	NULL
situ	NULL
probes	NULL
as	NULL
well	NULL
as	NULL
mouse	NULL
embryos	NULL
and	NULL
tissues	NULL
were	NULL
prepared	NULL
for	NULL
cryosectioning	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
analysis	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
3.3	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
loading	NULL
buffer	NULL
.	NULL

After	NULL
boiling	NULL
,	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
an	NULL
SDS-7	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

An	NULL
anti-mouse	NULL
c-Myb	NULL
type	NULL
I	NULL
monoclonal	NULL
antibody	NULL
that	NULL
cross-reacts	NULL
with	NULL
human	NULL
c-Myb	NULL
(	NULL
Upstate	NULL
Bio-technology	NULL
,	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
was	NULL
incubated	NULL
4°C	NULL
overnight	NULL
at	NULL
0.4	NULL
pg/ml	NULL
.	NULL

The	NULL
secondary	NULL
antibody	NULL
was	NULL
an	NULL
anti-mouse	NULL
horseradish	NULL
peroxidase	NULL
conjugate	NULL
;	NULL
bound	NULL
antibody	NULL
complexes	NULL
were	NULL
visualized	NULL
with	NULL
the	NULL
Amersham	NULL
enhanced	NULL
chemi-luminescence	NULL
system	NULL
.	NULL

Immunofluorescence	NULL
localization	NULL
of	NULL
c-Myb	NULL
.	NULL

A	NULL
total	NULL
of	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
cytocentrifuged	NULL
onto	NULL
glass	NULL
slides	NULL
,	NULL
and	NULL
fixed	NULL
with	NULL
acetone	NULL
.	NULL

Non-specific	NULL
binding	NULL
sites	NULL
were	NULL
blocked	NULL
with	NULL
PBS	NULL
that	NULL
contained	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
,	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
,	NULL
and	NULL
3	NULL
drops	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
per	NULL
10	NULL
ml	NULL
.	NULL

An	NULL
anti-mouse	NULL
c-Myb	NULL
type	NULL
I	NULL
monoclonal	NULL
antibody	NULL
at	NULL
50	NULL
pg/ml	NULL
in	NULL
1	NULL
%	NULL
PBS-1	NULL
%	NULL
BSA	NULL
was	NULL
allowed	NULL
to	NULL
interact	NULL
with	NULL
cells	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
a	NULL
wash	NULL
in	NULL
PBS-1	NULL
%	NULL
BSA	NULL
,	NULL
a	NULL
rabbit	NULL
anti-mouse	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fluorescein-conjugated	NULL
secondary	NULL
antibody	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
,	NULL
slide	NULL
covers	NULL
were	NULL
affixed	NULL
with	NULL
Antifade	NULL
medium	NULL
(	NULL
Oncor	NULL
)	NULL
containing	NULL
propidium	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

a	NULL
DNAse	NULL
I	NULL
HS	NULL
's	NULL
9.J	NULL
$	NULL
ko	NULL
ADA	NULL
t	NULL
UH	NULL
WY	NULL
3	NULL
:	NULL
i	NULL
--	NULL
HH	NULL
--	NULL
H	NULL
--	NULL
-E	NULL
GENE	NULL
F	NULL
2	NULL
3	NULL
0	NULL
4006	NULL
7	NULL
1012	NULL
Bs	NULL
It	NULL
_	NULL
enhancer	NULL
HS	NULL
II	NULL
domain	NULL
ie	NULL
3LEbF	NULL
;	NULL
z-	NULL
.	NULL

_-	NULL
i_	NULL
Facilitator	NULL
___|	NULL
°	NULL
SphI	NULL
``	NULL
25	NULL
IMCFc	NULL
SphI	NULL
_-_	NULL
ADA-NF	NULL
127	NULL
ENHANCER	NULL
_	NULL
APRC	NULL
_	NULL
TTGACTCACATGGCAGTTGGTGGTGGAGGGGAACAA	NULL
AP-1	NULL
c-myb	NULL
MAZ	NULL
RC	NULL
00	NULL
RL	NULL
0	NULL
R7	NULL
<	NULL
==	NULL
APRC	NULL
GSTmyb	NULL
0.7	NULL
~	NULL
>	NULL
-	NULL
WHY	NULL
Wo	NULL
Wihtwih	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Structure	NULL
of	NULL
the	NULL
human	NULL
ADA	NULL
gene	NULL
,	NULL
including	NULL
a	NULL
2.3-kb	NULL
fragment	NULL
LCR	NULL
,	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
's	NULL
)	NULL
II	NULL
and	NULL
III	NULL
,	NULL
enhancer	NULL
core	NULL
sequences	NULL
,	NULL
ADA-NF1	NULL
and	NULL
ADA-NF2	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
introduced	NULL
point	NULL
mutations	NULL
R1	NULL
and	NULL
R7	NULL
.	NULL

The	NULL
9-bp	NULL
c-Myb	NULL
consensus	NULL
and	NULL
adjacent	NULL
AP-1	NULL
sites	NULL
are	NULL
under-lined	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
labeled	NULL
APRC	NULL
and	NULL
purified	NULL
GSTmyb-0.7	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
major	NULL
shifted	NULL
complex	NULL
of	NULL
APRC	NULL
and	NULL
GSTmyb-0.7	NULL
is	NULL
indicated	NULL
(	NULL
arrow	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
indicated	NULL
as	NULL
concentration	NULL
ramps	NULL
,	NULL
was	NULL
performed	NULL
with	NULL
10-	NULL
,	NULL
40-	NULL
,	NULL
and	NULL
160-fold	NULL
molar	NULL
ex-cesses	NULL
.	NULL

Lane	NULL
1	NULL
is	NULL
APRC	NULL
probe	NULL
only	NULL
.	NULL

GST	NULL
protein	NULL
alone	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
specific	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

iodide	NULL
for	NULL
nucleic	NULL
acid	NULL
staining	NULL
.	NULL

Bound	NULL
antibody	NULL
complexes	NULL
were	NULL
visualized	NULL
with	NULL
an	NULL
Olympus	NULL
100	NULL
%	NULL
PlanApo	NULL
oil	NULL
objective	NULL
and	NULL
photographed	NULL
with	NULL
Ektar	NULL
100	NULL
film	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
and	NULL
transgenic	NULL
mice	NULL
.	NULL

A	NULL
mutagenic	NULL
oligonucleotide	NULL
was	NULL
used	NULL
to	NULL
alter	NULL
the	NULL
ADA-NFI1	NULL
site	NULL
within	NULL
the	NULL
2.3-kb	NULL
Sph1-Sph1	NULL
fragment	NULL
from	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
ADA	NULL
,	NULL
using	NULL
the	NULL
pAlter	NULL
vector	NULL
kit	NULL
(	NULL
Promega	NULL
Altered	NULL
Sites	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
was	NULL
confirmed	NULL
by	NULL
double-stranded	NULL
sequencing	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
ADA	NULL
CAT	NULL
reporter	NULL
5'acba	NULL
(	NULL
3	NULL
)	NULL
to	NULL
yield	NULL
plasmid	NULL
I	NULL
2.3	NULL
R7	NULL
CAT	NULL
.	NULL

The	NULL
transgene	NULL
fragment	NULL
was	NULL
isolated	NULL
from	NULL
this	NULL
plasmid	NULL
and	NULL
used	NULL
to	NULL
generate	NULL
independent	NULL
transgenic	NULL
mouse	NULL
lines	NULL
.	NULL

F	NULL
,	NULL
progeny	NULL
were	NULL
characterized	NULL
for	NULL
transgene	NULL
integrity	NULL
,	NULL
copy	NULL
number	NULL
,	NULL
and	NULL
CAT	NULL
expression	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
3	NULL
)	NULL
.	NULL

RESULTS	NULL
Natural	NULL
occurrence	NULL
of	NULL
an	NULL
in	NULL
vitro-identified	NULL
c-Myb	NULL
binding	NULL
site	NULL
.	NULL

By	NULL
the	NULL
selection	NULL
of	NULL
random	NULL
sequences	NULL
in	NULL
vitro	NULL
,	NULL
Howe	NULL
and	NULL
Watson	NULL
(	NULL
19	NULL
)	NULL
derived	NULL
a	NULL
9-bp	NULL
consensus	NULL
sequence	NULL
for	NULL
c-Myb	NULL
binding	NULL
,	NULL
not	NULL
previously	NULL
identified	NULL
in	NULL
vivo	NULL
,	NULL
that	NULL
is	NULL
present	NULL
within	NULL
the	NULL
core	NULL
of	NULL
the	NULL
ADA	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
directly	NULL
if	NULL
ADA	NULL
core	NULL
element	NULL
sequences	NULL
bind	NULL
to	NULL
c-Myb	NULL
,	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
human	NULL
c-Myb	NULL
protein	NULL
.	NULL

The	NULL
major	NULL
complex	NULL
formed	NULL
between	NULL
c-Myb	NULL
and	NULL
the	NULL
APRC	NULL
extended	NULL
core	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
was	NULL
effectively	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
unlabeled	NULL
APRC	NULL
or	NULL
RC	NULL
oligonucleotide	NULL
.	NULL

APRC	NULL
includes	NULL
the	NULL
28-bp	NULL
RC	NULL
core	NULL
and	NULL
an	NULL
adjacent	NULL
AP-1	NULL
site	NULL
,	NULL
which	NULL
evidently	NULL
was	NULL
not	NULL
required	NULL
for	NULL
c-Myb	NULL
binding	NULL
.	NULL

Within	NULL
the	NULL
RC	NULL
core	NULL
,	NULL
two	NULL
binding	NULL
sites	NULL
,	NULL
ADA-NF1	NULL
and	NULL
ADA-NF2	NULL
,	NULL
have	NULL
been	NULL
previously	NULL
defined	NULL
.	NULL

Both	NULL
sites	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
polymerized	NULL
core	NULL
element	NULL
to	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
aa	NULL
.	NULL

ame	NULL
sam	NULL
-	NULL
se	NULL
*	NULL
0	NULL
*	NULL
¢	NULL
o	NULL
a	NULL
6	NULL
6	NULL
6	NULL
6	NULL
6	NULL
o	NULL
147	NULL
5	NULL
12	NULL
2	NULL
E	NULL
$	NULL
1	NULL
2	NULL
197	NULL
0	NULL
1	NULL
o	NULL
1	NULL
&	NULL
87	NULL
>	NULL
1	NULL
2	NULL
1	NULL
§	NULL
g	NULL
3	NULL
1	NULL
9	NULL
1	NULL
<	NULL
4	NULL
43	NULL
i-	NULL
]	NULL
<	NULL
4	NULL
]	NULL
o	NULL
-	NULL
2-7	NULL
o-Reporter	NULL
:	NULL
ADA-RC	NULL
ADA-RC	NULL
ADA-R1i	NULL
ADA-R1	NULL
ADA-R7	NULL
ADA-R7	NULL
Effector	NULL
:	NULL
-	NULL
--	NULL
pRSVmyb	NULL
_	NULL
-	NULL
__	NULL
pRSVmyb	NULL
-	NULL
__	NULL
pRSVmyb	NULL
FIG	NULL
.	NULL

2.	NULL
c-Myb	NULL
transactivates	NULL
ADA	NULL
core	NULL
element	NULL
CAT	NULL
reporters	NULL
in	NULL
transiently	NULL
cotransfected	NULL
Raji	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
15	NULL
pg	NULL
of	NULL
expression	NULL
vector	NULL
pRSVmyb	NULL
and	NULL
7.5	NULL
ug	NULL
of	NULL
ADA	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
that	NULL
contained	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
RC	NULL
,	NULL
R1	NULL
,	NULL
or	NULL
R7	NULL
element	NULL
.	NULL

Duplicate	NULL
datum	NULL
points	NULL
are	NULL
shown	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
;	NULL
very	NULL
similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Conversion	NULL
of	NULL
[	NULL
**C	NULL
]	NULL
chloramphenicol	NULL
to	NULL
monoacetylated	NULL
product	NULL
was	NULL
quantitated	NULL
on	NULL
a	NULL
PhosphorImager	NULL
by	NULL
using	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

act	NULL
as	NULL
an	NULL
enhancer	NULL
in	NULL
transfected	NULL
Molt-4	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
for	NULL
the	NULL
site	NULL
specificity	NULL
of	NULL
c-Myb	NULL
interaction	NULL
,	NULL
two	NULL
oligonucleotides	NULL
with	NULL
point	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
ADA-NF1	NULL
or	NULL
ADA-NF2	NULL
site	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

Mutation	NULL
at	NULL
the	NULL
ADA-NF1	NULL
site	NULL
(	NULL
APR7	NULL
)	NULL
prevented	NULL
competition	NULL
for	NULL
c-Myb	NULL
protein	NULL
binding	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
at	NULL
the	NULL
ADA-NF2	NULL
site	NULL
(	NULL
APR1	NULL
)	NULL
allowed	NULL
competition	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
wild-type	NULL
APRC	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
identify	NULL
c-Myb	NULL
as	NULL
a	NULL
protein	NULL
which	NULL
binds	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
ADA-NF1	NULL
site	NULL
.	NULL

c-Myb	NULL
transactivates	NULL
ADA	NULL
enhancer	NULL
sequences	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
analysis	NULL
described	NULL
above	NULL
indicates	NULL
that	NULL
c-Myb	NULL
protein	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
ADA-NF1	NULL
site	NULL
but	NULL
does	NULL
not	NULL
address	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
and	NULL
transactivate	NULL
within	NULL
a	NULL
cell	NULL
.	NULL

Raji	NULL
B	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
pRSVmyb	NULL
and	NULL
CAT	NULL
reporter	NULL
construct	NULL
ADA-RC	NULL
,	NULL
which	NULL
contained	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
RC	NULL
core	NULL
oligonucleotide	NULL
placed	NULL
downstream	NULL
of	NULL
a	NULL
4-kb	NULL
human	NULL
ADA	NULL
promoter	NULL
and	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Raji	NULL
cells	NULL
express	NULL
minimal	NULL
ADA	NULL
and	NULL
exhibit	NULL
no	NULL
transactivation	NULL
from	NULL
the	NULL
thymic	NULL
enhancer	NULL
or	NULL
polymerized	NULL
core	NULL
element	NULL
(	NULL
3	NULL
)	NULL
.	NULL

c-Myb	NULL
re-producibly	NULL
transactivated	NULL
ADA-RC	NULL
approximately	NULL
30-fold	NULL
over	NULL
the	NULL
value	NULL
for	NULL
the	NULL
reporter	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Control	NULL
transfections	NULL
using	NULL
of	NULL
a	NULL
version	NULL
of	NULL
c-Myb	NULL
with	NULL
the	NULL
transactivation	NULL
domain	NULL
deleted	NULL
(	NULL
10	NULL
)	NULL
nearly	NULL
eliminated	NULL
transactivation	NULL
of	NULL
ADA-RC	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cotransfection	NULL
was	NULL
also	NULL
performed	NULL
with	NULL
pRSVmyb	NULL
and	NULL
ADA	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
that	NULL
contained	NULL
polymerized	NULL
oligonucleotides	NULL
with	NULL
mutated	NULL
sites	NULL
for	NULL
ADA-NF1	NULL
(	NULL
ADA-R7	NULL
)	NULL
or	NULL
ADA-NF2	NULL
(	NULL
ADA-R1	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

ADA-NFI	NULL
site	NULL
mutation	NULL
strongly	NULL
diminished	NULL
c-Myb	NULL
transactivation	NULL
,	NULL
but	NULL
mutation	NULL
of	NULL
the	NULL
ADA-NF2	NULL
site	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
c-Myb	NULL
transactivation	NULL
.	NULL

Also	NULL
,	NULL
c-Myb	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
transactivation	NULL
of	NULL
the	NULL
4-kb	NULL
ADA	NULL
promoter	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
c-Myb	NULL
is	NULL
competent	NULL
to	NULL
transactivate	NULL
promoter	NULL
activity	NULL
via	NULL
a	NULL
minimal	NULL
enhancer	NULL
site	NULL
.	NULL

c-Myb	NULL
transactivates	NULL
ADA	NULL
enhancer	NULL
sequences	NULL
in	NULL
yeast	NULL
chromatin	NULL
.	NULL

Endogenous	NULL
enhancers	NULL
and	NULL
LCRs	NULL
function	NULL
within	NULL
c-Myb	NULL
,	NULL
AN	NULL
LCR	NULL
DETERMINANT	NULL
FACTOR	NULL
5709	NULL
FIG	NULL
.	NULL

3.	NULL
c-Myb	NULL
transactivates	NULL
chromatin-integrated	NULL
ADA	NULL
core	NULL
elements	NULL
in	NULL
yeast	NULL
cells	NULL
.	NULL

c-Myb	NULL
expression	NULL
vectors	NULL
CCC	NULL
,	NULL
CCd	NULL
,	NULL
and	NULL
dCC	NULL
were	NULL
introduced	NULL
as	NULL
2	NULL
m	NULL
plasmids	NULL
(	NULL
p	NULL
)	NULL
in	NULL
yeast	NULL
strains	NULL
containing	NULL
lacZ	NULL
reporter	NULL
constructs	NULL
mim-1A	NULL
wt	NULL
,	NULL
mim-1A	NULL
mut	NULL
,	NULL
ADA-RC	NULL
,	NULL
ADA-R1	NULL
,	NULL
and	NULL
ADA-R7	NULL
integrated	NULL
at	NULL
the	NULL
URA3	NULL
locus	NULL
.	NULL

For	NULL
all	NULL
constructions	NULL
,	NULL
the	NULL
putative	NULL
myb	NULL
response	NULL
elements	NULL
were	NULL
placed	NULL
immediately	NULL
5	NULL
'	NULL
of	NULL
the	NULL
yeast	NULL
TATA	NULL
element	NULL
.	NULL

The	NULL
parental	NULL
TATA-lacZ	NULL
reporter	NULL
contains	NULL
promoter-only	NULL
sequences	NULL
and	NULL
had	NULL
very	NULL
low	NULL
activity	NULL
under	NULL
all	NULL
conditions	NULL
.	NULL

B-Galactosidase	NULL
(	NULL
-gal	NULL
)	NULL
units	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Miller	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
independent	NULL
transformant	NULL
clones	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
showed	NULL
highly	NULL
reproducible	NULL
activation	NULL
profiles	NULL
.	NULL

cop	NULL
.	NULL

,	NULL
copies	NULL
.	NULL

the	NULL
context	NULL
of	NULL
chromatin	NULL
,	NULL
which	NULL
may	NULL
be	NULL
considerably	NULL
less	NULL
permissive	NULL
for	NULL
transactivation	NULL
than	NULL
transiently	NULL
transfected	NULL
plasmids	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
function	NULL
of	NULL
the	NULL
ADA	NULL
LCR	NULL
in	NULL
chromatin	NULL
is	NULL
dependent	NULL
on	NULL
a	NULL
series	NULL
of	NULL
architecturally	NULL
constrained	NULL
elements	NULL
(	NULL
2	NULL
)	NULL
.	NULL

To	NULL
test	NULL
c-Myb	NULL
's	NULL
ability	NULL
to	NULL
transactivate	NULL
from	NULL
the	NULL
isolated	NULL
enhancer	NULL
core	NULL
in	NULL
chromatin	NULL
,	NULL
ADA-RC	NULL
lacZ	NULL
reporter	NULL
genes	NULL
were	NULL
constructed	NULL
and	NULL
integrated	NULL
into	NULL
the	NULL
yeast	NULL
genome	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
ability	NULL
of	NULL
c-Myb	NULL
to	NULL
transactivate	NULL
reporter	NULL
strains	NULL
containing	NULL
wild-type	NULL
and	NULL
mutant	NULL
ADA	NULL
core	NULL
elements	NULL
with	NULL
the	NULL
known	NULL
c-Myb-responsive	NULL
element	NULL
,	NULL
mim-1A	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
Chen	NULL
and	NULL
Lipsick	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
also	NULL
evaluated	NULL
N-	NULL
and	NULL
C-terminal	NULL
truncated	NULL
forms	NULL
of	NULL
c-Myb	NULL
(	NULL
dCC	NULL
and	NULL
CCd	NULL
,	NULL
respectively	NULL
)	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
roles	NULL
of	NULL
c-Myb	NULL
terminal	NULL
domains	NULL
that	NULL
may	NULL
modulate	NULL
transactivation	NULL
from	NULL
the	NULL
ADA	NULL
core	NULL
element	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
c-Myb	NULL
strongly	NULL
transactivated	NULL
the	NULL
four-copy	NULL
ADA-RC	NULL
element	NULL
(	NULL
60	NULL
%	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
five-copy	NULL
mim-1A	NULL
reporter	NULL
.	NULL

The	NULL
three-copy	NULL
ADA-R1	NULL
mutation	NULL
was	NULL
transactivated	NULL
nearly	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ADA-RC	NULL
mutation	NULL
,	NULL
but	NULL
the	NULL
ADA-R7	NULL
mutation	NULL
caused	NULL
a	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
loss	NULL
of	NULL
activity	NULL
.	NULL

The	NULL
mutated	NULL
mim-1A	NULL
site	NULL
was	NULL
apparently	NULL
even	NULL
more	NULL
detrimental	NULL
than	NULL
the	NULL
ADA-R7	NULL
mutation	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
results	NULL
are	NULL
corroborative	NULL
of	NULL
those	NULL
observed	NULL
in	NULL
transient	NULL
cotransfection	NULL
assays	NULL
and	NULL
additionally	NULL
indicate	NULL
that	NULL
c-Myb	NULL
can	NULL
recognize	NULL
and	NULL
transactivate	NULL
from	NULL
the	NULL
ADA-NF1	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
yeast	NULL
chromatin	NULL
.	NULL

N-terminal	NULL
and	NULL
C-terminal	NULL
truncated	NULL
c-Myb	NULL
forms	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
transactivate	NULL
from	NULL
the	NULL
mim-1A	NULL
element	NULL
as	NULL
much	NULL
as	NULL
60	NULL
to	NULL
70	NULL
%	NULL
less	NULL
than	NULL
full-length	NULL
c-Myb	NULL
in	NULL
yeast	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
reproduced	NULL
these	NULL
results	NULL
for	NULL
the	NULL
mim-1A	NULL
element	NULL
and	NULL
5710	NULL
ESS	NULL
ET	NULL
AL	NULL
.	NULL

<	NULL
'	NULL
o	NULL
$	NULL
dis	NULL
'	NULL
ig	NULL
:	NULL
s	NULL
o	NULL
E	NULL
w-	NULL
§	NULL
8	NULL
£	NULL
92.5	NULL
cem	NULL
aes	NULL
kb	NULL
69	NULL
``	NULL
ae	NULL
2.8-	NULL
_	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
c-myb	NULL
in	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
10	NULL
mg	NULL
)	NULL
from	NULL
Molt-4	NULL
,	NULL
CEM	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
was	NULL
electrophoresed	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
human	NULL
c-myb	NULL
fragment	NULL
.	NULL

The	NULL
approximately	NULL
3.8-kb	NULL
band	NULL
appears	NULL
equivalently	NULL
expressed	NULL
by	NULL
Molt-4	NULL
and	NULL
CEM	NULL
cells	NULL
but	NULL
is	NULL
absent	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
RNA	NULL
was	NULL
evident	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
intensity	NULL
of	NULL
rRNA	NULL
bands	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
of	NULL
Molt	NULL
,	NULL
CEM	NULL
,	NULL
and	NULL
Raji	NULL
cell	NULL
lines	NULL
were	NULL
electrophoresed	NULL
through	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
c-Myb	NULL
monoclonal	NULL
antibody	NULL
(	NULL
type	NULL
I	NULL
;	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
see-ondary	NULL
antibody	NULL
conjugated	NULL
to	NULL
peroxidase	NULL
.	NULL

Complexes	NULL
were	NULL
visualized	NULL
by	NULL
chemi-luminescence	NULL
.	NULL

A	NULL
single	NULL
band	NULL
,	NULL
of	NULL
approximately	NULL
75	NULL
kDa	NULL
,	NULL
corresponding	NULL
to	NULL
c-Myb	NULL
protein	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
Molt-4	NULL
and	NULL
CEM	NULL
cells	NULL
but	NULL
not	NULL
Raji	NULL
cells	NULL
.	NULL

showed	NULL
for	NULL
the	NULL
ADA	NULL
core	NULL
element	NULL
that	NULL
C-terminal	NULL
truncation	NULL
of	NULL
c-Myb	NULL
(	NULL
CCd	NULL
)	NULL
also	NULL
caused	NULL
reduced	NULL
transactivation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
mim-1A	NULL
,	NULL
the	NULL
N-terminal	NULL
truncated	NULL
form	NULL
of	NULL
c-Myb	NULL
(	NULL
dCC	NULL
)	NULL
did	NULL
not	NULL
cause	NULL
a	NULL
decreased	NULL
activation	NULL
of	NULL
the	NULL
ADA-RC	NULL
element	NULL
in	NULL
that	NULL
it	NULL
showed	NULL
strong	NULL
transactivation	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
CCC	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
RC	NULL
and	NULL
mim-1A	NULL
elements	NULL
can	NULL
not	NULL
be	NULL
due	NULL
to	NULL
the	NULL
adjacent	NULL
ADA-NF2	NULL
site	NULL
because	NULL
its	NULL
mutation	NULL
(	NULL
ADA-R1	NULL
)	NULL
also	NULL
showed	NULL
similar	NULL
strong	NULL
activation	NULL
by	NULL
both	NULL
dCC	NULL
and	NULL
CCC	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
c-Myb	NULL
interacts	NULL
with	NULL
the	NULL
ADA	NULL
core	NULL
element	NULL
differently	NULL
than	NULL
the	NULL
mim-1A	NULL
element	NULL
.	NULL

Expression	NULL
of	NULL
c-myb	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

For	NULL
c-Myb	NULL
to	NULL
activate	NULL
the	NULL
ADA	NULL
gene	NULL
in	NULL
developing	NULL
thymocytes	NULL
,	NULL
it	NULL
must	NULL
be	NULL
present	NULL
in	NULL
the	NULL
appropriate	NULL
cells	NULL
.	NULL

Molt-4	NULL
is	NULL
an	NULL
immature	NULL
CD4*	NULL
CD8*	NULL
T-cell	NULL
lymphoblastoid	NULL
line	NULL
that	NULL
produces	NULL
high	NULL
amounts	NULL
of	NULL
ADA	NULL
and	NULL
strongly	NULL
transactivates	NULL
from	NULL
the	NULL
ADA	NULL
core	NULL
element	NULL
.	NULL

CEM	NULL
is	NULL
a	NULL
CD4*	NULL
CD8~	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
one-fifth	NULL
as	NULL
much	NULL
ADA	NULL
mRNA	NULL
as	NULL
Molt-4	NULL
and	NULL
demonstrates	NULL
a	NULL
reduced	NULL
response	NULL
to	NULL
the	NULL
RC	NULL
core	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Raji	NULL
B	NULL
cells	NULL
have	NULL
less	NULL
than	NULL
1	NULL
%	NULL
as	NULL
much	NULL
ADA	NULL
as	NULL
Molt-4	NULL
cells	NULL
and	NULL
completely	NULL
fail	NULL
to	NULL
transactivate	NULL
the	NULL
core	NULL
element	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
Molt-4	NULL
and	NULL
CEM	NULL
lines	NULL
both	NULL
exhibit	NULL
strong	NULL
expression	NULL
of	NULL
c-Myb	NULL
as	NULL
a	NULL
single	NULL
band	NULL
corresponding	NULL
to	NULL
3.8-kb	NULL
mRNA	NULL
and	NULL
a	NULL
protein	NULL
of	NULL
75	NULL
kDa	NULL
,	NULL
whereas	NULL
Raji	NULL
B-cells	NULL
express	NULL
no	NULL
detectable	NULL
c-Myb	NULL
mRNA	NULL
or	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
equally	NULL
high	NULL
levels	NULL
of	NULL
c-Myb	NULL
are	NULL
present	NULL
in	NULL
the	NULL
T-cell	NULL
lines	NULL
,	NULL
suggesting	NULL
that	NULL
factors	NULL
in	NULL
addition	NULL
to	NULL
c-Myb	NULL
are	NULL
likely	NULL
to	NULL
determine	NULL
the	NULL
difference	NULL
in	NULL
core	NULL
element	NULL
enhancer	NULL
strength	NULL
in	NULL
Molt-4	NULL
and	NULL
CEM	NULL
T	NULL
cells	NULL
.	NULL

c-Myb	NULL
is	NULL
localized	NULL
in	NULL
discrete	NULL
subnuclear	NULL
structures	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

As	NULL
c-Myb	NULL
appears	NULL
to	NULL
be	NULL
equivalently	NULL
expressed	NULL
in	NULL
Molt-4	NULL
and	NULL
CEM	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
function	NULL
of	NULL
c-Myb	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
might	NULL
be	NULL
the	NULL
result	NULL
of	NULL
alternative	NULL
interactions	NULL
or	NULL
its	NULL
distribution	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

When	NULL
the	NULL
c-Myb	NULL
monoclonal	NULL
antibody	NULL
and	NULL
a	NULL
secondary	NULL
fluorescein-conjugated	NULL
antibody	NULL
were	NULL
used	NULL
,	NULL
c-Myb	NULL
protein	NULL
was	NULL
largely	NULL
localized	NULL
to	NULL
discrete	NULL
,	NULL
intensely	NULL
labeled	NULL
speckles	NULL
present	NULL
throughout	NULL
the	NULL
nuclei	NULL
of	NULL
Molt-4	NULL
and	NULL
CEM	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

For	NULL
most	NULL
cells	NULL
,	NULL
from	NULL
15	NULL
to	NULL
more	NULL
than	NULL
50	NULL
speckles	NULL
were	NULL
evident	NULL
.	NULL

However	NULL
,	NULL
occasional	NULL
cells	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
c-Myb	NULL
within	NULL
their	NULL
nuclei	NULL
.	NULL

The	NULL
nuclear	NULL
morphology	NULL
of	NULL
these	NULL
cells	NULL
suggests	NULL
that	NULL
they	NULL
are	NULL
in	NULL
M	NULL
phase	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
short	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

half-life	NULL
and	NULL
cell	NULL
cycle	NULL
regulation	NULL
of	NULL
c-Myb	NULL
(	NULL
23	NULL
,	NULL
35	NULL
)	NULL
.	NULL

CEM	NULL
and	NULL
Molt-4	NULL
cells	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
differ	NULL
in	NULL
their	NULL
nuclear	NULL
patterns	NULL
,	NULL
but	NULL
some	NULL
CEM	NULL
cells	NULL
appeared	NULL
to	NULL
have	NULL
additional	NULL
cytoplasmic	NULL
signal	NULL
,	NULL
also	NULL
present	NULL
as	NULL
discrete	NULL
particles	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
signal	NULL
in	NULL
both	NULL
Molt-4	NULL
and	NULL
CEM	NULL
cells	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
real	NULL
because	NULL
Raji	NULL
cells	NULL
,	NULL
which	NULL
lack	NULL
c-Myb	NULL
by	NULL
both	NULL
Northern	NULL
or	NULL
Western	NULL
analyses	NULL
,	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
background	NULL
immunofluorescence	NULL
staining	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
cytoplasmic	NULL
c-Myb	NULL
signal	NULL
could	NULL
be	NULL
observed	NULL
in	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
Molt-4	NULL
or	NULL
CEM	NULL
cells	NULL
that	NULL
lacked	NULL
a	NULL
nuclear	NULL
signal	NULL
.	NULL

Also	NULL
,	NULL
there	NULL
appeared	NULL
to	NULL
be	NULL
some	NULL
heterogeneity	NULL
of	NULL
signal	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
with	NULL
both	NULL
a	NULL
finely	NULL
dispersed	NULL
fluorescence	NULL
and	NULL
the	NULL
definite	NULL
presence	NULL
of	NULL
speckles	NULL
that	NULL
appeared	NULL
to	NULL
be	NULL
similar	NULL
in	NULL
size	NULL
to	NULL
those	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
cell	NULL
's	NULL
nuclei	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
cycle	NULL
of	NULL
c-Myb	NULL
synthesis	NULL
,	NULL
assembly	NULL
,	NULL
trafficking	NULL
,	NULL
and	NULL
degradation	NULL
within	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
intact	NULL
enhancer	NULL
requires	NULL
the	NULL
core	NULL
c-Myb	NULL
site	NULL
for	NULL
activity	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
.	NULL

Polymerization	NULL
of	NULL
individual	NULL
cis	NULL
elements	NULL
often	NULL
exaggerates	NULL
their	NULL
relative	NULL
contribution	NULL
and	NULL
may	NULL
not	NULL
reflect	NULL
their	NULL
role	NULL
or	NULL
requirement	NULL
within	NULL
complex	NULL
enhancers	NULL
.	NULL

We	NULL
therefore	NULL
made	NULL
reporter	NULL
constructs	NULL
that	NULL
contained	NULL
the	NULL
2.3-kb	NULL
extended	NULL
ADA	NULL
enhancer	NULL
with	NULL
and	NULL
without	NULL
the	NULL
2-bp	NULL
ADA-NF1	NULL
mutation	NULL
.	NULL

In	NULL
transiently	NULL
transfected	NULL
Molt-4	NULL
cells	NULL
,	NULL
I	NULL
2.3	NULL
R7	NULL
CAT	NULL
had	NULL
approximately	NULL
4	NULL
%	NULL
as	NULL
much	NULL
CAT	NULL
activity	NULL
as	NULL
the	NULL
unmutated	NULL
parental	NULL
LCR	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
intact	NULL
enhancer	NULL
was	NULL
strongly	NULL
dependent	NULL
on	NULL
the	NULL
single	NULL
c-Myb	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
result	NULL
supports	NULL
previous	NULL
hypotheses	NULL
that	NULL
elements	NULL
within	NULL
the	NULL
central	NULL
core	NULL
region	NULL
are	NULL
es-sential	NULL
,	NULL
even	NULL
when	NULL
both	NULL
flanking	NULL
elements	NULL
are	NULL
intact	NULL
.	NULL

LCR	NULL
activity	NULL
requires	NULL
a	NULL
c-Myb	NULL
site	NULL
for	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Transient	NULL
transfection	NULL
analyses	NULL
can	NULL
exaggerate	NULL
the	NULL
importance	NULL
of	NULL
single	NULL
elements	NULL
and	NULL
be	NULL
insensitive	NULL
to	NULL
additional	NULL
sites	NULL
and	NULL
factors	NULL
responsible	NULL
for	NULL
activating	NULL
gene	NULL
expression	NULL
in	NULL
dynamic	NULL
lineages	NULL
of	NULL
an	NULL
intact	NULL
animal	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
observe	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
ADA-NF1	NULL
c-Myb	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
ADA	NULL
LCR	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
ADA	NULL
LCR	NULL
has	NULL
been	NULL
defined	NULL
previously	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
generate	NULL
position-independent	NULL
transgene	NULL
expression	NULL
that	NULL
is	NULL
proportional	NULL
to	NULL
gene	NULL
copy	NULL
number	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Six	NULL
independent	NULL
lines	NULL
of	NULL
I	NULL
2.3	NULL
R7	NULL
CAT	NULL
mice	NULL
were	NULL
derived	NULL
and	NULL
analyzed	NULL
for	NULL
CAT	NULL
reporter	NULL
activity	NULL
and	NULL
gene	NULL
copy	NULL
number	NULL
.	NULL

In	NULL
all	NULL
lines	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
consistently	NULL
and	NULL
considerably	NULL
higher	NULL
in	NULL
the	NULL
thymus	NULL
than	NULL
it	NULL
was	NULL
in	NULL
the	NULL
spleen	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
or	NULL
liver	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
thymus	NULL
,	NULL
three	NULL
lines	NULL
exhibited	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
expected	NULL
CAT	NULL
activity	NULL
per	NULL
gene	NULL
copy	NULL
,	NULL
two	NULL
lines	NULL
exhibited	NULL
approximately	NULL
10	NULL
%	NULL
of	NULL
the	NULL
expected	NULL
expression	NULL
,	NULL
and	NULL
interestingly	NULL
,	NULL
one	NULL
line	NULL
exhibited	NULL
essentially	NULL
100	NULL
%	NULL
of	NULL
the	NULL
expected	NULL
activity	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
c-Myb	NULL
mutation	NULL
was	NULL
confirmed	NULL
in	NULL
each	NULL
of	NULL
these	NULL
lines	NULL
,	NULL
but	NULL
in	NULL
the	NULL
high-expressing	NULL
line	NULL
2	NULL
,	NULL
Southern	NULL
blot	NULL
analysis	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
nonconventional	NULL
concatemeric	NULL
array	NULL
in	NULL
which	NULL
there	NULL
were	NULL
variable-size	NULL
genomic	NULL
insertions	NULL
in	NULL
half	NULL
of	NULL
the	NULL
20	NULL
transgene	NULL
copies	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
data	NULL
show	NULL
that	NULL
among	NULL
independent	NULL
transgenic	NULL
lines	NULL
containing	NULL
the	NULL
c-Myb	NULL
site	NULL
mutation	NULL
,	NULL
there	NULL
is	NULL
poor	NULL
and	NULL
inconsistent	NULL
LCR	NULL
function	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
gene	NULL
copy	NULL
number	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
cripples	NULL
the	NULL
entire	NULL
ADA	NULL
LCR	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
analysis	NULL
of	NULL
e-myb	NULL
,	NULL
ADA	NULL
,	NULL
and	NULL
CAT	NULL
transgene	NULL
expression	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
potential	NULL
of	NULL
c-Myb	NULL
to	NULL
regulate	NULL
the	NULL
ADA	NULL
LCR	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
and	NULL
correlate	NULL
the	NULL
patterns	NULL
of	NULL
mouse	NULL
c-Myb	NULL
,	NULL
mouse	NULL
ADA	NULL
,	NULL
and	NULL
human	NULL
ADA	NULL
CAT	NULL
transgene	NULL
expression	NULL
.	NULL

Published	NULL
analyses	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
expression	NULL
pattern	NULL
of	NULL
c-Myb	NULL
in	NULL
the	NULL
mouse	NULL
have	NULL
been	NULL
based	NULL
only	NULL
on	NULL
Northern	NULL
blot	NULL
analyses	NULL
and	NULL
suggest	NULL
that	NULL
c-Myb	NULL
is	NULL
present	NULL
at	NULL
a	NULL
high	NULL
level	NULL
in	NULL
cortical	NULL
thymocytes	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
32	NULL
)	NULL
but	NULL
at	NULL
a	NULL
much	NULL
lower	NULL
level	NULL
in	NULL
most	NULL
other	NULL
tissues	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

7a	NULL
)	NULL
of	NULL
a	NULL
gestational	NULL
day	NULL
16	NULL
mouse	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
c-Myb	NULL
,	NULL
AN	NULL
LCR	NULL
DETERMINANT	NULL
FACTOR	NULL
5711	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Immunofluorescence	NULL
localization	NULL
of	NULL
c-Myb	NULL
in	NULL
discrete	NULL
subnuclear	NULL
structures	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Molt-4	NULL
cells	NULL
.	NULL

(	NULL
b	NULL
)	NULL
CEM	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cytospun	NULL
onto	NULL
slides	NULL
,	NULL
fixed	NULL
for	NULL
10	NULL
min	NULL
in	NULL
acetone	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
c-Myb	NULL
monoclonal	NULL
antibody	NULL
followed	NULL
with	NULL
a	NULL
fluorescein-conjugated	NULL
secondary	NULL
antibody	NULL
and	NULL
Antifade	NULL
mounting	NULL
medium	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

Nuclear	NULL
DNA	NULL
appears	NULL
red	NULL
as	NULL
a	NULL
result	NULL
of	NULL
propidium	NULL
iodide	NULL
counterstaining	NULL
,	NULL
and	NULL
fluorescein	NULL
fluorescence	NULL
appears	NULL
green	NULL
over	NULL
the	NULL
cytoplasm	NULL
and	NULL
yellow	NULL
over	NULL
the	NULL
nuclear	NULL
background	NULL
.	NULL

Omission	NULL
of	NULL
the	NULL
primary	NULL
monoclonal	NULL
antibody	NULL
abolished	NULL
immunostaining	NULL
.	NULL

Raji	NULL
cells	NULL
exhibited	NULL
no	NULL
signal	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

5712	NULL
ESS	NULL
ET	NULL
AL	NULL
.	NULL

to	NULL
in	NULL
2	NULL
1.5	NULL
0	NULL
in	NULL
Jig	NULL
aa	NULL
f	NULL
a	NULL
f	NULL
ora	NULL
a	NULL
ae	NULL
forall	NULL
rua	NULL
CAT	NULL
Activity	NULL
(	NULL
%	NULL
Conversion	NULL
)	NULL
o	NULL
123	NULL
CAT	NULL
12.3	NULL
RZ	NULL
CAT	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

The	NULL
2.3-kb	NULL
ADA	NULL
enhancer	NULL
domain	NULL
requires	NULL
a	NULL
functional	NULL
c-Myb	NULL
site	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Molt-4	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
1	NULL
2.3	NULL
CAT	NULL
or	NULL
1	NULL
2.3	NULL
R7	NULL
CAT	NULL
reporter	NULL
construct	NULL
.	NULL

Data	NULL
represent	NULL
mean	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
(	NULL
+	NULL
standard	NULL
deviation	NULL
)	NULL
from	NULL
five	NULL
experiments	NULL
using	NULL
two	NULL
different	NULL
preparations	NULL
of	NULL
DNA	NULL
.	NULL

Percent	NULL
conversion	NULL
was	NULL
determined	NULL
with	NULL
a	NULL
PhosphorImager	NULL
.	NULL

fetus	NULL
reveals	NULL
very	NULL
strong	NULL
c-myb	NULL
expression	NULL
in	NULL
the	NULL
cortical	NULL
region	NULL
of	NULL
the	NULL
thymus	NULL
as	NULL
well	NULL
as	NULL
its	NULL
expected	NULL
high	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
of	NULL
the	NULL
fetal	NULL
liver	NULL
.	NULL

Interestingly	NULL
,	NULL
there	NULL
is	NULL
also	NULL
strong	NULL
expression	NULL
of	NULL
c-myb	NULL
in	NULL
both	NULL
tracheal	NULL
and	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
of	NULL
the	NULL
developing	NULL
lung	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
very	NULL
little	NULL
expression	NULL
of	NULL
c-myb	NULL
in	NULL
nearly	NULL
all	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
medullary	NULL
thymocytes	NULL
.	NULL

In	NULL
older	NULL
animals	NULL
,	NULL
the	NULL
thymic	NULL
medulla	NULL
becomes	NULL
more	NULL
prominent	NULL
and	NULL
c-myb	NULL
expression	NULL
remains	NULL
confined	NULL
entirely	NULL
to	NULL
the	NULL
cortical	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
cortical-medullary	NULL
distribution	NULL
of	NULL
c-Myb	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
ADA	NULL
in	NULL
the	NULL
mature	NULL
thymus	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
endogenous	NULL
mouse	NULL
ADA	NULL
and	NULL
ADA	NULL
CAT	NULL
transgene	NULL
mRNAs	NULL
was	NULL
also	NULL
analyzed	NULL
in	NULL
fetal	NULL
mouse	NULL
tissues	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Strikingly	NULL
,	NULL
CAT	NULL
mRNA	NULL
expressed	NULL
by	NULL
the	NULL
wild-type	NULL
(	NULL
4/12	NULL
ADA	NULL
CAT	NULL
)	NULL
LCR	NULL
transgene	NULL
in	NULL
day	NULL
16	NULL
fetuses	NULL
was	NULL
intensely	NULL
expressed	NULL
and	NULL
localized	NULL
to	NULL
the	NULL
thymus	NULL
(	NULL
Fig	NULL
.	NULL

7b	NULL
)	NULL
,	NULL
as	NULL
was	NULL
endogenous	NULL
mouse	NULL
ADA	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

7¢	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
c-Myb	NULL
,	NULL
ADA	NULL
and	NULL
CAT	NULL
mRNAs	NULL
TABLE	NULL
1	NULL
.	NULL

Mutation	NULL
of	NULL
a	NULL
single	NULL
c-Myb	NULL
site	NULL
disables	NULL
the	NULL
ADA	NULL
LCR	NULL
in	NULL
transgenic	NULL
thymocytes	NULL
``	NULL
Construct	NULL
Mouse	NULL
line	NULL
Transgene	NULL
Thy	NULL
?	NULL

!	NULL

”	NULL
CAT	NULL
copy	NULL
no	NULL
.	NULL

activity/copy	NULL
12.3	NULL
CAT	NULL
1	NULL
5	NULL
29,000	NULL
22	NULL
3	NULL
26,000	NULL
23	NULL
8	NULL
63,000	NULL
24	NULL
6	NULL
55,000	NULL
25	NULL
2	NULL
52,000	NULL
41	NULL
3	NULL
38,000	NULL
42	NULL
45	NULL
24,000	NULL
12.3	NULL
R7	NULL
CAT	NULL
2	NULL
20°	NULL
20,500	NULL
3	NULL
1	NULL
311	NULL
4	NULL
1	NULL
393	NULL
5	NULL
10	NULL
4,388	NULL
6	NULL
2	NULL
38	NULL
7	NULL
2	NULL
4,500	NULL
@	NULL
All	NULL
mice	NULL
analyzed	NULL
were	NULL
5-	NULL
to	NULL
10-week-old	NULL
F	NULL
,	NULL
transgenic	NULL
I	NULL
2.3	NULL
CAT	NULL
mice	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
for	NULL
descriptions	NULL
of	NULL
lines	NULL
22	NULL
to	NULL
25	NULL
,	NULL
41	NULL
and	NULL
42	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

8	NULL
of	NULL
reference	NULL
3	NULL
;	NULL
data	NULL
for	NULL
line	NULL
1	NULL
are	NULL
from	NULL
Haynes	NULL
and	NULL
Wiginton	NULL
[	NULL
17a	NULL
]	NULL
)	NULL
.	NULL

Transgene	NULL
copy	NULL
numbers	NULL
were	NULL
determined	NULL
by	NULL
quantitative	NULL
Southern	NULL
blotting	NULL
using	NULL
a	NULL
PhosphorImager	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
picomoles	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
per	NULL
100	NULL
mg	NULL
of	NULL
protein	NULL
per	NULL
hour	NULL
.	NULL

Southern	NULL
analysis	NULL
of	NULL
line	NULL
2	NULL
indicates	NULL
numerous	NULL
additional	NULL
sequences	NULL
present	NULL
within	NULL
the	NULL
transgene	NULL
concatemer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

were	NULL
much	NULL
more	NULL
restricted	NULL
.	NULL

No	NULL
detectable	NULL
expression	NULL
of	NULL
either	NULL
occurred	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
or	NULL
in	NULL
the	NULL
upper	NULL
airway	NULL
epithelium	NULL
of	NULL
the	NULL
developing	NULL
lung	NULL
.	NULL

Since	NULL
occasional	NULL
transgenic	NULL
lines	NULL
that	NULL
contained	NULL
the	NULL
c-Myb	NULL
site	NULL
mutation	NULL
retained	NULL
some	NULL
,	NULL
or	NULL
in	NULL
one	NULL
case	NULL
considerable	NULL
,	NULL
total	NULL
thymic	NULL
CAT	NULL
activity	NULL
,	NULL
we	NULL
examined	NULL
this	NULL
effect	NULL
using	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Among	NULL
independent	NULL
transgenic	NULL
lines	NULL
that	NULL
contained	NULL
the	NULL
mutant	NULL
I	NULL
2.3	NULL
R7	NULL
transgene	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
expression	NULL
in	NULL
lines	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
in	NULL
any	NULL
of	NULL
the	NULL
tissues	NULL
examined	NULL
,	NULL
including	NULL
thymus	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
spleen	NULL
.	NULL

Not	NULL
even	NULL
occasional	NULL
cells	NULL
were	NULL
expressing	NULL
reporter	NULL
gene	NULL
.	NULL

This	NULL
finding	NULL
indicates	NULL
that	NULL
diminished	NULL
expression	NULL
was	NULL
affecting	NULL
all	NULL
of	NULL
the	NULL
cells	NULL
uniformly	NULL
,	NULL
rather	NULL
than	NULL
causing	NULL
an	NULL
alteration	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
within	NULL
the	NULL
tissue	NULL
that	NULL
activate	NULL
the	NULL
locus	NULL
.	NULL

However	NULL
,	NULL
we	NULL
find	NULL
it	NULL
interesting	NULL
that	NULL
the	NULL
higher-expressing	NULL
lines	NULL
2	NULL
and	NULL
5	NULL
exhibited	NULL
strong	NULL
and	NULL
uniform	NULL
CAT	NULL
mRNA	NULL
signal	NULL
over	NULL
the	NULL
cortical	NULL
thymocytes	NULL
,	NULL
with	NULL
appropriate	NULL
lack	NULL
of	NULL
expression	NULL
over	NULL
the	NULL
medullary	NULL
thymocytes	NULL
.	NULL

In	NULL
the	NULL
limited	NULL
other	NULL
tissues	NULL
analyzed	NULL
from	NULL
these	NULL
lines	NULL
,	NULL
no	NULL
ectopic	NULL
expression	NULL
of	NULL
CAT	NULL
mRNA	NULL
was	NULL
ob-served	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
addition	NULL
to	NULL
that	NULL
of	NULL
c-Myb	NULL
are	NULL
capable	NULL
of	NULL
specifying	NULL
thymocyte-specific	NULL
gene	NULL
expression	NULL
and	NULL
that	NULL
occasional	NULL
integration	NULL
sites	NULL
are	NULL
capable	NULL
of	NULL
overcoming	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
c-Myb	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
ADA	NULL
LCR	NULL
.	NULL

DISCUSSION	NULL
Deletional	NULL
analyses	NULL
of	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
ADA	NULL
gene	NULL
first	NULL
intron	NULL
indicate	NULL
a	NULL
complex	NULL
hierarchy	NULL
of	NULL
cis	NULL
elements	NULL
that	NULL
combine	NULL
to	NULL
form	NULL
a	NULL
thymocyte-specific	NULL
enhancer	NULL
and	NULL
LCR	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Chromatin	NULL
structure	NULL
studies	NULL
indicate	NULL
that	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
stepwise	NULL
process	NULL
in	NULL
which	NULL
factor	NULL
accessibility	NULL
to	NULL
regulatory	NULL
sequences	NULL
precedes	NULL
the	NULL
formation	NULL
of	NULL
DNase	NULL
I	NULL
hy-persensitivity	NULL
.	NULL

The	NULL
enhancer	NULL
is	NULL
able	NULL
to	NULL
generate	NULL
initial	NULL
accessi-bility	NULL
,	NULL
but	NULL
the	NULL
distal	NULL
flanking	NULL
facilitators	NULL
participate	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
DNase	NULL
I-hypersensitive	NULL
LCR	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
in	NULL
vivo	NULL
enhancer	NULL
function	NULL
.	NULL

We	NULL
have	NULL
now	NULL
shown	NULL
that	NULL
c-Myb	NULL
binds	NULL
to	NULL
and	NULL
transactivates	NULL
from	NULL
a	NULL
single	NULL
element	NULL
within	NULL
the	NULL
enhancer	NULL
core	NULL
.	NULL

c-Myb	NULL
is	NULL
present	NULL
within	NULL
T-lymphoblast	NULL
cells	NULL
that	NULL
support	NULL
the	NULL
function	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
is	NULL
also	NULL
strongly	NULL
expressed	NULL
in	NULL
cortical	NULL
thymocytes	NULL
in	NULL
which	NULL
the	NULL
LCR	NULL
is	NULL
strongly	NULL
active	NULL
.	NULL

In	NULL
the	NULL
cortex	NULL
of	NULL
fetal	NULL
thymus	NULL
,	NULL
there	NULL
is	NULL
coincident	NULL
high-level	NULL
expression	NULL
of	NULL
ec-myb	NULL
and	NULL
endogenous	NULL
mouse	NULL
ADA	NULL
as	NULL
well	NULL
as	NULL
ADA	NULL
LCR-directed	NULL
CAT	NULL
gene	NULL
expression	NULL
.	NULL

Within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
LCR	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
caused	NULL
a	NULL
severe	NULL
loss	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
both	NULL
T-cell	NULL
transfection	NULL
assays	NULL
and	NULL
the	NULL
majority	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
within	NULL
the	NULL
highly	NULL
organized	NULL
ADA	NULL
thymic	NULL
regulatory	NULL
region	NULL
,	NULL
there	NULL
is	NULL
a	NULL
central	NULL
role	NULL
for	NULL
a	NULL
single	NULL
c-Myb	NULL
binding	NULL
site	NULL
.	NULL

Since	NULL
c-Myb	NULL
can	NULL
perform	NULL
a	NULL
dominant	NULL
functional	NULL
role	NULL
in	NULL
the	NULL
ADA	NULL
LCR	NULL
and	NULL
is	NULL
present	NULL
at	NULL
a	NULL
very	NULL
high	NULL
level	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
c-Myb	NULL
performs	NULL
a	NULL
similarly	NULL
dominating	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
multiple	NULL
genes	NULL
necessary	NULL
for	NULL
T-cell	NULL
Iymphogenesis	NULL
.	NULL

c-Myb	NULL
is	NULL
a	NULL
nonredundant	NULL
determinant	NULL
of	NULL
early-stage	NULL
hema-topoiesis	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
severe	NULL
multilineage	NULL
anemia	NULL
in	NULL
embryonic	NULL
day	NULL
14	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
deletion	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Both	NULL
immature	NULL
myeloid	NULL
and	NULL
erythroid	NULL
cell	NULL
lines	NULL
express	NULL
c-Myb	NULL
(	NULL
17	NULL
,	NULL
24	NULL
)	NULL
,	NULL
and	NULL
their	NULL
induced	NULL
differentiation	NULL
requires	NULL
down-regulation	NULL
of	NULL
c-Myb	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
c-mmyb	NULL
antisense	NULL
oligonucleotides	NULL
can	NULL
inhibit	NULL
the	NULL
progression	NULL
of	NULL
human	NULL
chronic	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
in	NULL
a	NULL
scid	NULL
mouse	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
results	NULL
have	NULL
suggested	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
erythroid	NULL
and	NULL
myeloid	NULL
lineages	NULL
,	NULL
but	NULL
a	NULL
similar	NULL
critical	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
more	NULL
difficult	NULL
to	NULL
delin-cate	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
c-Myb	NULL
,	NULL
AN	NULL
LCR	NULL
DETERMINANT	NULL
FACTOR	NULL
5713	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
analysis	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
c-myb	NULL
,	NULL
endogenous	NULL
ADA	NULL
,	NULL
and	NULL
CAT	NULL
mRNAs	NULL
.	NULL

(	NULL
a	NULL
)	NULL
e-mmyb	NULL
expression	NULL
in	NULL
an	NULL
embryonic	NULL
day	NULL
16.5	NULL
mouse	NULL
.	NULL

The	NULL
immature	NULL
thymus	NULL
(	NULL
thy	NULL
)	NULL
shows	NULL
very	NULL
high	NULL
expression	NULL
in	NULL
cortical	NULL
thymocytes	NULL
.	NULL

The	NULL
liver	NULL
(	NULL
Ii	NULL
)	NULL
shows	NULL
c-myb	NULL
expression	NULL
exclusively	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Additional	NULL
expression	NULL
is	NULL
seen	NULL
in	NULL
epithelial	NULL
cells	NULL
of	NULL
developing	NULL
lung	NULL
(	NULL
Iu	NULL
)	NULL
.	NULL

c-myb	NULL
expression	NULL
is	NULL
also	NULL
high	NULL
in	NULL
day	NULL
15	NULL
thymus	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
X	NULL
13	NULL
.	NULL

(	NULL
b	NULL
)	NULL
CAT	NULL
expression	NULL
in	NULL
transgenic	NULL
4/12	NULL
ADA	NULL
CAT	NULL
fetal	NULL
day	NULL
15	NULL
cells	NULL
.	NULL

The	NULL
thymus	NULL
shows	NULL
a	NULL
strong	NULL
signal	NULL
,	NULL
but	NULL
there	NULL
is	NULL
no	NULL
detectable	NULL
expression	NULL
in	NULL
hematopoietic	NULL
or	NULL
lung	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
X	NULL
26	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Endogenous	NULL
ADA	NULL
expression	NULL
in	NULL
transgenic	NULL
4/12	NULL
ADA	NULL
CAT	NULL
fetal	NULL
day	NULL
15	NULL
cells	NULL
.	NULL

The	NULL
thymus	NULL
again	NULL
shows	NULL
a	NULL
strong	NULL
signal	NULL
,	NULL
but	NULL
there	NULL
is	NULL
no	NULL
detectable	NULL
expression	NULL
in	NULL
hematopoietic	NULL
or	NULL
lung	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
X26	NULL
.	NULL

(	NULL
d	NULL
)	NULL
CAT	NULL
expression	NULL
in	NULL
transgenic	NULL
4/12	NULL
ADA	NULL
CAT	NULL
adult	NULL
thymus	NULL
.	NULL

Cortical	NULL
thymocytes	NULL
(	NULL
C	NULL
)	NULL
are	NULL
exclusively	NULL
labeled	NULL
;	NULL
medullary	NULL
thymocytes	NULL
(	NULL
M	NULL
)	NULL
are	NULL
negative	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
X	NULL
26	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
CAT	NULL
expression	NULL
is	NULL
absent	NULL
in	NULL
adult	NULL
thymus	NULL
from	NULL
transgenic	NULL
I	NULL
2.3	NULL
R7	NULL
line	NULL
6	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
x65	NULL
.	NULL

(	NULL
f	NULL
)	NULL
CAT	NULL
expression	NULL
in	NULL
adult	NULL
thymus	NULL
transgenic	NULL
I	NULL
2.3	NULL
R7	NULL
line	NULL
2	NULL
is	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
a	NULL
normal	NULL
LCR	NULL
CAT	NULL
transgene	NULL
with	NULL
an	NULL
appropriate	NULL
cortical-medullary	NULL
expression	NULL
pattern	NULL
.	NULL

Final	NULL
magnification	NULL
,	NULL
x26	NULL
.	NULL

5714	NULL
ESS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
developing	NULL
T	NULL
cells	NULL
was	NULL
suspected	NULL
from	NULL
observations	NULL
of	NULL
its	NULL
expression	NULL
in	NULL
thymocytes	NULL
(	NULL
32	NULL
,	NULL
35	NULL
)	NULL
,	NULL
but	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
e-nyb	NULL
knockout	NULL
mouse	NULL
was	NULL
not	NULL
revealing	NULL
,	NULL
presumably	NULL
because	NULL
hematopoietic	NULL
failure	NULL
precedes	NULL
thymic	NULL
development	NULL
.	NULL

Distinguishing	NULL
the	NULL
role	NULL
of	NULL
c-Myb	NULL
in	NULL
hematopoietic	NULL
multilineage	NULL
progenitors	NULL
from	NULL
an	NULL
additional	NULL
role	NULL
as	NULL
a	NULL
T-cell	NULL
developmental	NULL
factor	NULL
requires	NULL
cell-type-specific	NULL
targeting	NULL
.	NULL

Re-cently	NULL
,	NULL
Badiani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
4	NULL
)	NULL
produced	NULL
transgenic	NULL
mice	NULL
with	NULL
dom-inant-negative	NULL
c-mmyb	NULL
transgenes	NULL
under	NULL
the	NULL
control	NULL
of	NULL
CD2	NULL
regulatory	NULL
elements	NULL
.	NULL

Thymocyte	NULL
expression	NULL
of	NULL
dominant-neg-ative	NULL
c-Myb	NULL
derivatives	NULL
caused	NULL
thymocyte	NULL
number	NULL
reduction	NULL
,	NULL
apparently	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
to	NULL
form	NULL
double-positive	NULL
thymocytes	NULL
.	NULL

These	NULL
results	NULL
are	NULL
suggestive	NULL
of	NULL
a	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
T-cell	NULL
ontogeny	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
dominant-nega-tive	NULL
c-Myb	NULL
forms	NULL
represent	NULL
broadly	NULL
acting	NULL
effectors	NULL
,	NULL
able	NULL
to	NULL
distort	NULL
gene	NULL
expression	NULL
and	NULL
differentiation	NULL
in	NULL
lineages	NULL
that	NULL
are	NULL
not	NULL
necessarily	NULL
dependent	NULL
on	NULL
the	NULL
native	NULL
protein	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
selective	NULL
disruption	NULL
of	NULL
the	NULL
thymic	NULL
c-myb	NULL
gene	NULL
could	NULL
be	NULL
more	NULL
destructive	NULL
to	NULL
T-cell	NULL
development	NULL
than	NULL
expression	NULL
of	NULL
a	NULL
domi-nant-negative	NULL
form	NULL
.	NULL

Other	NULL
evidence	NULL
that	NULL
c-Myb	NULL
regulates	NULL
T-cell-specific	NULL
gene	NULL
expression	NULL
includes	NULL
the	NULL
identification	NULL
of	NULL
c-Myb-responsive	NULL
elements	NULL
in	NULL
the	NULL
T-cell	NULL
receptor	NULL
8	NULL
gene	NULL
(	NULL
18	NULL
)	NULL
,	NULL
the	NULL
CD4	NULL
gene	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
the	NULL
c-myb	NULL
gene	NULL
itself	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
the	NULL
T-cell	NULL
receptor	NULL
8	NULL
gene	NULL
,	NULL
mutation	NULL
of	NULL
a	NULL
c-Myb	NULL
binding	NULL
site	NULL
,	NULL
or	NULL
an	NULL
adjacent	NULL
core	NULL
factor	NULL
site	NULL
,	NULL
crippled	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
370-bp	NULL
enhancer	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
.	NULL

For	NULL
the	NULL
other	NULL
thymocyte-expressed	NULL
genes	NULL
,	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
the	NULL
c-Myb	NULL
sites	NULL
to	NULL
their	NULL
regulation	NULL
is	NULL
unclear	NULL
,	NULL
as	NULL
the	NULL
hierarchical	NULL
organization	NULL
of	NULL
their	NULL
promoters	NULL
or	NULL
enhancer	NULL
(	NULL
s	NULL
)	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
defined	NULL
.	NULL

Our	NULL
data	NULL
extend	NULL
the	NULL
suggestion	NULL
that	NULL
c-Myb	NULL
is	NULL
a	NULL
powerful	NULL
effector	NULL
for	NULL
some	NULL
T-cell	NULL
enhancers	NULL
and	NULL
additionally	NULL
demonstrate	NULL
that	NULL
a	NULL
single	NULL
site	NULL
for	NULL
its	NULL
binding	NULL
can	NULL
act	NULL
as	NULL
an	NULL
organizer	NULL
for	NULL
LCR	NULL
function	NULL
.	NULL

There	NULL
is	NULL
a	NULL
marked	NULL
discrepancy	NULL
between	NULL
the	NULL
activational	NULL
potential	NULL
of	NULL
endogenously	NULL
expressed	NULL
c-Myb	NULL
and	NULL
that	NULL
of	NULL
cotransfected	NULL
overexpressed	NULL
c-Myb	NULL
.	NULL

When	NULL
polymerized	NULL
core	NULL
element	NULL
reporter	NULL
is	NULL
transfected	NULL
into	NULL
Molt-4	NULL
T	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
a	NULL
strict	NULL
requirement	NULL
for	NULL
both	NULL
ADA-NF1	NULL
and	NULL
ADA-NF2	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
introduction	NULL
of	NULL
exogenous	NULL
c-Myb	NULL
can	NULL
not	NULL
circumvent	NULL
this	NULL
requirement	NULL
for	NULL
both	NULL
binding	NULL
sites	NULL
in	NULL
Molt-4	NULL
cells	NULL
(	NULL
13a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
an	NULL
intact	NULL
ADA-NF1	NULL
site	NULL
was	NULL
required	NULL
when	NULL
c-Myb	NULL
was	NULL
added	NULL
exogenously	NULL
by	NULL
cotransfection	NULL
in	NULL
Raji	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
CEM	NULL
(	NULL
13a	NULL
)	NULL
,	NULL
and	NULL
yeast	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
cells	NULL
.	NULL

Given	NULL
that	NULL
Molt-4	NULL
and	NULL
CEM	NULL
T	NULL
cells	NULL
appear	NULL
to	NULL
express	NULL
comparable	NULL
amounts	NULL
of	NULL
c-Myb	NULL
,	NULL
variations	NULL
of	NULL
some	NULL
additional	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
modulating	NULL
endogenous	NULL
c-Myb	NULL
function	NULL
is	NULL
the	NULL
likely	NULL
explanation	NULL
for	NULL
why	NULL
the	NULL
polymerized	NULL
core	NULL
is	NULL
a	NULL
stronger	NULL
element	NULL
in	NULL
Molt-4	NULL
than	NULL
CEM	NULL
cells	NULL
.	NULL

An	NULL
additional	NULL
hypothesis	NULL
is	NULL
that	NULL
there	NULL
are	NULL
distinct	NULL
forms	NULL
of	NULL
c-Myb	NULL
present	NULL
in	NULL
some	NULL
T	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
,	NULL
perhaps	NULL
as	NULL
a	NULL
result	NULL
of	NULL
alternative	NULL
mRNA	NULL
splicing	NULL
(	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
if	NULL
present	NULL
,	NULL
these	NULL
forms	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
by	NULL
Western	NULL
analysis	NULL
with	NULL
the	NULL
type	NULL
I	NULL
Upstate	NULL
Biotechnology	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Deletional	NULL
analyses	NULL
of	NULL
the	NULL
ADA	NULL
enhancer	NULL
provide	NULL
additional	NULL
supportive	NULL
evidence	NULL
for	NULL
the	NULL
hypothesis	NULL
that	NULL
endogenously	NULL
expressed	NULL
c-Myb	NULL
acts	NULL
in	NULL
partnership	NULL
with	NULL
other	NULL
factors	NULL
.	NULL

In	NULL
transfected	NULL
Molt-4	NULL
cells	NULL
,	NULL
strong	NULL
enhancer	NULL
activity	NULL
required	NULL
the	NULL
enhancer	NULL
core	NULL
to	NULL
be	NULL
adjoined	NULL
to	NULL
elements	NULL
present	NULL
in	NULL
sequences	NULL
located	NULL
up	NULL
to	NULL
100	NULL
to	NULL
200	NULL
bp	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
of	NULL
the	NULL
core	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
both	NULL
flanking	NULL
regions	NULL
conferred	NULL
neither	NULL
greater	NULL
activation	NULL
nor	NULL
alteration	NULL
in	NULL
cell	NULL
type	NULL
specificity	NULL
than	NULL
was	NULL
evident	NULL
with	NULL
only	NULL
a	NULL
single	NULL
flanking	NULL
segment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
single	NULL
c-Myb	NULL
site	NULL
abolished	NULL
enhancer	NULL
activity	NULL
with	NULL
both	NULL
flanking	NULL
elements	NULL
present	NULL
.	NULL

Finally	NULL
,	NULL
ADA	NULL
LCR	NULL
expression	NULL
occurred	NULL
only	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
regulatory	NULL
factors	NULL
expressed	NULL
in	NULL
thymocytes	NULL
,	NULL
not	NULL
in	NULL
the	NULL
other	NULL
c-myb-expressing	NULL
fetal	NULL
hepatic	NULL
hematopoietic	NULL
or	NULL
lung	NULL
epithelial	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

additional	NULL
support	NULL
for	NULL
the	NULL
hypothesis	NULL
that	NULL
c-Myb-directed	NULL
gene	NULL
expression	NULL
requires	NULL
additional	NULL
factors	NULL
for	NULL
target	NULL
gene	NULL
specificity	NULL
in	NULL
disparate	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
thymocytes	NULL
,	NULL
pre-erythroid	NULL
or	NULL
myeloid	NULL
cells	NULL
,	NULL
or	NULL
even	NULL
lung	NULL
epithelium	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
central	NULL
role	NULL
of	NULL
c-Myb	NULL
in	NULL
the	NULL
ADA	NULL
LCR	NULL
stands	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
requirement	NULL
for	NULL
additional	NULL
factors	NULL
within	NULL
different	NULL
cellular	NULL
compartments	NULL
.	NULL

S.	NULL
cerevisiae	NULL
represents	NULL
an	NULL
evolutionarily	NULL
divergent	NULL
cell	NULL
type	NULL
within	NULL
which	NULL
c-Myb	NULL
can	NULL
be	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
overcome	NULL
the	NULL
structural	NULL
constraints	NULL
imposed	NULL
by	NULL
a	NULL
chromatin	NULL
environment	NULL
.	NULL

In	NULL
transgenic	NULL
animals	NULL
,	NULL
the	NULL
dependence	NULL
of	NULL
the	NULL
intact	NULL
ADA	NULL
LCR	NULL
on	NULL
a	NULL
large	NULL
number	NULL
of	NULL
heterologous	NULL
elements	NULL
could	NULL
mask	NULL
the	NULL
capability	NULL
of	NULL
c-Myb	NULL
to	NULL
act	NULL
in	NULL
chromatin	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
yeast	NULL
cells	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
core	NULL
element	NULL
itself	NULL
could	NULL
be	NULL
evaluated	NULL
in	NULL
a	NULL
chromatin	NULL
environment	NULL
without	NULL
the	NULL
need	NULL
for	NULL
an	NULL
extended	NULL
complex	NULL
regulatory	NULL
region	NULL
as	NULL
required	NULL
in	NULL
transgenic	NULL
mouse	NULL
thymocytes	NULL
.	NULL

Expression	NULL
vectors	NULL
encoding	NULL
wild-type	NULL
and	NULL
truncated	NULL
forms	NULL
of	NULL
c-Myb	NULL
allowed	NULL
us	NULL
to	NULL
evaluate	NULL
domains	NULL
implicated	NULL
to	NULL
modify	NULL
the	NULL
actions	NULL
or	NULL
interactions	NULL
of	NULL
c-Myb	NULL
(	NULL
8	NULL
)	NULL
.	NULL

An	NULL
interesting	NULL
difference	NULL
was	NULL
evident	NULL
between	NULL
the	NULL
divergent	NULL
ADA	NULL
and	NULL
mim-1A	NULL
c-Myb	NULL
binding	NULL
sites	NULL
in	NULL
which	NULL
only	NULL
the	NULL
C-terminal	NULL
c-Myb	NULL
truncation	NULL
decreased	NULL
transactivation	NULL
of	NULL
the	NULL
ADA	NULL
enhancer	NULL
core	NULL
.	NULL

That	NULL
there	NULL
is	NULL
a	NULL
difference	NULL
between	NULL
c-Myb	NULL
domain	NULL
requirements	NULL
for	NULL
activation	NULL
of	NULL
an	NULL
ADA	NULL
response	NULL
element	NULL
and	NULL
the	NULL
mim-1A	NULL
myeloid	NULL
response	NULL
element	NULL
provides	NULL
an	NULL
additional	NULL
suggestion	NULL
as	NULL
to	NULL
how	NULL
c-Myb	NULL
can	NULL
act	NULL
on	NULL
distinct	NULL
target	NULL
sequences	NULL
in	NULL
combination	NULL
with	NULL
other	NULL
factors	NULL
found	NULL
in	NULL
different	NULL
cellular	NULL
contexts	NULL
.	NULL

The	NULL
N-terminal	NULL
deletion	NULL
effect	NULL
on	NULL
the	NULL
ADA	NULL
core	NULL
element	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
of	NULL
c-Myb	NULL
DNA	NULL
interaction	NULL
in	NULL
which	NULL
the	NULL
amino-terminal	NULL
helix	NULL
1	NULL
serves	NULL
only	NULL
to	NULL
modify	NULL
the	NULL
recognition	NULL
of	NULL
the	NULL
target	NULL
binding	NULL
site	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
for	NULL
organized	NULL
regulatory	NULL
factor	NULL
interactions	NULL
that	NULL
involve	NULL
c-Myb	NULL
is	NULL
also	NULL
suggested	NULL
by	NULL
its	NULL
immunofluorescence	NULL
observations	NULL
in	NULL
Molt-4	NULL
and	NULL
CEM	NULL
cells	NULL
.	NULL

c-Myb	NULL
was	NULL
evident	NULL
in	NULL
large	NULL
intranuclear	NULL
speckled	NULL
structures	NULL
,	NULL
broadly	NULL
similar	NULL
to	NULL
those	NULL
that	NULL
have	NULL
been	NULL
observed	NULL
for	NULL
splicing	NULL
and	NULL
polyadenylation	NULL
processes	NULL
and	NULL
factors	NULL
(	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
these	NULL
c-Myb-containing	NULL
structures	NULL
represent	NULL
a	NULL
direct	NULL
visualization	NULL
of	NULL
T-cell	NULL
transcriptional	NULL
complexes	NULL
.	NULL

The	NULL
requirement	NULL
of	NULL
the	NULL
ADA	NULL
LCR	NULL
(	NULL
2	NULL
)	NULL
and	NULL
other	NULL
cell-specific	NULL
LCRs	NULL
(	NULL
20	NULL
)	NULL
for	NULL
extended	NULL
cis-regula-tory	NULL
regions	NULL
may	NULL
reflect	NULL
what	NULL
is	NULL
required	NULL
for	NULL
assembly	NULL
into	NULL
large	NULL
intranuclear	NULL
structures	NULL
such	NULL
as	NULL
those	NULL
implied	NULL
by	NULL
the	NULL
``	NULL
my-bosome	NULL
.	NULL
``	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
determine	NULL
the	NULL
identity	NULL
of	NULL
component	NULL
subunits	NULL
and	NULL
if	NULL
they	NULL
contain	NULL
factors	NULL
that	NULL
directly	NULL
interact	NULL
with	NULL
c-Myb	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

One	NULL
transgenic	NULL
line	NULL
,	NULL
I	NULL
2.3	NULL
CAT	NULL
R7-2	NULL
,	NULL
exhibited	NULL
essentially	NULL
wild-type	NULL
expression	NULL
,	NULL
suggesting	NULL
a	NULL
position-dependent	NULL
escape	NULL
mechanism	NULL
.	NULL

The	NULL
simplest	NULL
explanation	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
line	NULL
is	NULL
that	NULL
its	NULL
transgene	NULL
has	NULL
integrated	NULL
into	NULL
an	NULL
active	NULL
chromatin	NULL
region	NULL
that	NULL
provides	NULL
a	NULL
compensatory	NULL
effect	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
c-Myb	NULL
binding	NULL
site	NULL
.	NULL

Because	NULL
all	NULL
of	NULL
the	NULL
other	NULL
sites	NULL
are	NULL
present	NULL
,	NULL
the	NULL
architecture	NULL
of	NULL
a	NULL
multifactor	NULL
complex	NULL
could	NULL
be	NULL
preserved	NULL
.	NULL

This	NULL
complex	NULL
could	NULL
even	NULL
include	NULL
c-Myb	NULL
,	NULL
perhaps	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
multiple	NULL
other	NULL
factors	NULL
through	NULL
its	NULL
C-terminal	NULL
leucine	NULL
zipper	NULL
region	NULL
(	NULL
14	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
some	NULL
contexts	NULL
,	NULL
c-Myb	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
without	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
c-Myb	NULL
binding	NULL
site	NULL
or	NULL
even	NULL
its	NULL
DNA	NULL
binding	NULL
domain	NULL
as	NULL
long	NULL
as	NULL
other	NULL
specific	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
present	NULL
(	NULL
15	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
c-Myb	NULL
site-mutated	NULL
transgene	NULL
can	NULL
acquire	NULL
function	NULL
,	NULL
most	NULL
transgenic	NULL
lines	NULL
do	NULL
not	NULL
allow	NULL
the	NULL
thymocyte-specific	NULL
transcriptional	NULL
regulators	NULL
to	NULL
activate	NULL
the	NULL
enhancer	NULL
region	NULL
.	NULL

This	NULL
observation	NULL
indicates	NULL
that	NULL
the	NULL
single	NULL
c-Myb	NULL
site	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
LCR	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
the	NULL
localization	NULL
of	NULL
c-Myb	NULL
in	NULL
discrete	NULL
subnuclear	NULL
regions	NULL
represents	NULL
its	NULL
concentration	NULL
within	NULL
transcription	NULL
centers	NULL
.	NULL

In	NULL
the	NULL
developing	NULL
thymus	NULL
,	NULL
multiple	NULL
enabling	NULL
and	NULL
restricting	NULL
factors	NULL
may	NULL
interact	NULL
with	NULL
c-Myb	NULL
to	NULL
create	NULL
a	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
powerful	NULL
deterministic	NULL
complex	NULL
that	NULL
selectively	NULL
activates	NULL
the	NULL
target	NULL
genes	NULL
required	NULL
for	NULL
T-cell	NULL
lymphogenesis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Eric	NULL
Westin	NULL
,	NULL
Agnes	NULL
Cuddihy	NULL
,	NULL
Micheal	NULL
Kuehl	NULL
,	NULL
Cathy	NULL
Ley	NULL
Ebert	NULL
,	NULL
Rui-Hong	NULL
Chien	NULL
,	NULL
and	NULL
Joe	NULL
Lipsick	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
enthusiasm	NULL
,	NULL
Shelley	NULL
Barton	NULL
and	NULL
Steve	NULL
Potter	NULL
for	NULL
reading	NULL
the	NULL
manu-script	NULL
,	NULL
A.	NULL
Cuddihy	NULL
and	NULL
M.	NULL
Kuehl	NULL
for	NULL
pRSVmyb	NULL
,	NULL
R.	NULL
H.	NULL
Chien	NULL
for	NULL
mim1la-LacZ	NULL
and	NULL
Myb	NULL
yeast	NULL
expression	NULL
plasmids	NULL
,	NULL
E.	NULL
Westin	NULL
for	NULL
pMbm-1	NULL
,	NULL
Karen	NULL
Yager	NULL
for	NULL
transgene	NULL
microinjection	NULL
,	NULL
and	NULL
Kathy	NULL
Saal-feld	NULL
for	NULL
excellence	NULL
in	NULL
situ	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
research	NULL
grants	NULL
HD19919	NULL
(	NULL
J.H	NULL
.	NULL
)	NULL

and	NULL
DK47022	NULL
(	NULL
B.A	NULL
.	NULL
)	NULL

,	NULL
and	NULL
a	NULL
basic	NULL
research	NULL
grant	NULL
from	NULL
the	NULL
March	NULL
of	NULL
Dimes	NULL
Birth	NULL
Defects	NULL
Foundation	NULL
.	NULL

K.E	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
NIH	NULL
training	NULL
grant	NULL
HLO7527	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aronow	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Lattier	NULL
,	NULL
R.	NULL
Silbiger	NULL
,	NULL
M.	NULL
Dusing	NULL
,	NULL
J.	NULL
Hutton	NULL
,	NULL
G.	NULL
Jones	NULL
,	NULL
J	NULL
.	NULL

Stock	NULL
,	NULL
J.	NULL
McNeish	NULL
,	NULL
S.	NULL
Potter	NULL
,	NULL
D.	NULL
Witte	NULL
,	NULL
and	NULL
D.	NULL
Wiginton	NULL
.	NULL

1989	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
complex	NULL
regulatory	NULL
array	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1384-400	NULL
.	NULL

2	NULL
.	NULL

Aronow	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
C.	NULL
A.	NULL
Ebert	NULL
,	NULL
M.	NULL
T.	NULL
Valerius	NULL
,	NULL
S.	NULL
S.	NULL
Potter	NULL
,	NULL
D.	NULL
A.	NULL
Wiginton	NULL
,	NULL
D.	NULL
P.	NULL
Witte	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Hutton	NULL
.	NULL

1995	NULL
.	NULL

Dissecting	NULL
a	NULL
locus	NULL
control	NULL
region	NULL
:	NULL
facilitation	NULL
of	NULL
enhancer	NULL
function	NULL
by	NULL
extended	NULL
enhancer-flanking	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1123-1135	NULL
.	NULL

3	NULL
.	NULL

Aronow	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
R.	NULL
N.	NULL
Silbiger	NULL
,	NULL
M.	NULL
R.	NULL
Dusing	NULL
,	NULL
J.	NULL
L.	NULL
Stock	NULL
,	NULL
K.	NULL
L.	NULL
Yager	NULL
,	NULL
S.	NULL
S.	NULL
Potter	NULL
,	NULL
J.	NULL
J.	NULL
Hutton	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Wiginton	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
thymic	NULL
regulatory	NULL
region	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
generate	NULL
position-independent	NULL
transgene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
:	NULL
4170-4185	NULL
.	NULL

4	NULL
.	NULL

Badiani	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Corbella	NULL
,	NULL
D.	NULL
Kioussis	NULL
,	NULL
J.	NULL
Marvel	NULL
,	NULL
and	NULL
K.	NULL
Weston	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
interfering	NULL
alleles	NULL
define	NULL
a	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:770-782	NULL
.	NULL

5	NULL
.	NULL

Bhaumik	NULL
,	NULL
D.	NULL
,	NULL
B.	NULL
Yang	NULL
,	NULL
T.	NULL
Trangas	NULL
,	NULL
J.	NULL
S.	NULL
Bartlett	NULL
,	NULL
M.	NULL
S.	NULL
Coleman	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Sorscher	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
tripartite	NULL
basal	NULL
promoter	NULL
which	NULL
regulates	NULL
human	NULL
terminal	NULL
deoxynucleotidy	NULL
]	NULL
transferase	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:15861-15867	NULL
.	NULL

6	NULL
.	NULL

Blencowe	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nickerson	NULL
,	NULL
R.	NULL
Issner	NULL
,	NULL
S.	NULL
Penman	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1994	NULL
.	NULL

Association	NULL
of	NULL
nuclear	NULL
matrix	NULL
antigens	NULL
with	NULL
exon-containing	NULL
splicing	NULL
complexes	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

127:593-607	NULL
.	NULL

7	NULL
.	NULL

Caterina	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
D.	NULL
J.	NULL
Ciavatta	NULL
,	NULL
D.	NULL
Donze	NULL
,	NULL
R.	NULL
R.	NULL
Behringer	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Townes	NULL
.	NULL

1994	NULL
.	NULL

Multiple	NULL
elements	NULL
in	NULL
human	NULL
beta-globin	NULL
locus	NULL
control	NULL
region	NULL
5	NULL
'	NULL
HS	NULL
2	NULL
are	NULL
involved	NULL
in	NULL
enhancer	NULL
activity	NULL
and	NULL
position-independent	NULL
,	NULL
transgene	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:1006-1111	NULL
.	NULL

8	NULL
.	NULL

Chen	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Lipsick	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
transcriptional	NULL
activation	NULL
by	NULL
v-myb	NULL
and	NULL
c-myb	NULL
in	NULL
animal	NULL
cells	NULL
and	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4423-31	NULL
.	NULL

9	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
1993	NULL
.	NULL

A	NULL
reagent	NULL
for	NULL
the	NULL
single-step	NULL
simultaneous	NULL
isolation	NULL
of	NULL
RNA	NULL
,	NULL
DNA	NULL
and	NULL
proteins	NULL
from	NULL
cell	NULL
and	NULL
tissue	NULL
samples	NULL
.	NULL

BioTechniques	NULL
15:532-534	NULL
,	NULL
536-537	NULL
.	NULL

10	NULL
.	NULL

Cuddihy	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
L.	NULL
A.	NULL
Brents	NULL
,	NULL
N.	NULL
Aziz	NULL
,	NULL
T.	NULL
P.	NULL
Bender	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Kueh	NULL
]	NULL
.	NULL

1993	NULL
.	NULL

Only	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
of	NULL
c-Myb	NULL
are	NULL
required	NULL
to	NULL
block	NULL
terminal	NULL
differentiation	NULL
of	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3505-3513	NULL
.	NULL

11	NULL
.	NULL

Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1994	NULL
.	NULL

Chromatin	NULL
domains	NULL
as	NULL
potential	NULL
units	NULL
of	NULL
eukaryotic	NULL
gene	NULL
function	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4260-264	NULL
.	NULL

12	NULL
.	NULL

Dubendorff	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
L.	NULL
J.	NULL
Whittaker	NULL
,	NULL
J.	NULL
T.	NULL
Eltman	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Lipsick	NULL
.	NULL

1992	NULL
.	NULL

Carboxy-terminal	NULL
elements	NULL
of	NULL
c-Myb	NULL
negatively	NULL
regulate	NULL
transcriptional	NULL
activation	NULL
in	NULL
cis	NULL
and	NULL
in	NULL
trans	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

62524-2535	NULL
.	NULL

13	NULL
.	NULL

Durfee	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
A.	NULL
Mancini	NULL
,	NULL
D.	NULL
Jones	NULL
,	NULL
S.	NULL
J.	NULL
Elledge	NULL
,	NULL
and	NULL
W.	NULL
H.	NULL
Lee	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
amino-terminal	NULL
region	NULL
of	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
binds	NULL
a	NULL
novel	NULL
nuclear	NULL
matrix	NULL
protein	NULL
that	NULL
co-localizes	NULL
to	NULL
centers	NULL
for	NULL
RNA	NULL
processing	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

127:609-22	NULL
.	NULL

13a.Ess	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
B.	NULL
Aronow	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

14	NULL
.	NULL

Favier	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Gonda	NULL
.	NULL

1994	NULL
.	NULL

Detection	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
leucine	NULL
zipper	NULL
motif	NULL
of	NULL
c-Myb	NULL
.	NULL

Oncogene	NULL
9:305-311.	NULL
c-Myb	NULL
,	NULL
AN	NULL
LCR	NULL
DETERMINANT	NULL
FACTOR	NULL
5715	NULL
15	NULL
.	NULL

Foos	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Natour	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Klempnauer	NULL
.	NULL

1993	NULL
.	NULL

TATA-box	NULL
dependent	NULL
trans-activation	NULL
of	NULL
the	NULL
human	NULL
HSP70	NULL
promoter	NULL
by	NULL
Myb	NULL
proteins	NULL
.	NULL

Oncogene	NULL
8:1775-1782	NULL
.	NULL

16	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
U.	NULL
Novak	NULL
,	NULL
R.	NULL
Gelinas	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
beta-globin	NULL
locus	NULL
activation	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5439-5443	NULL
.	NULL

17	NULL
.	NULL

Gonda	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Metcalf	NULL
.	NULL

1984	NULL
.	NULL

Expression	NULL
of	NULL
myb	NULL
,	NULL
myc	NULL
and	NULL
fos	NULL
proto-oncogenes	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
a	NULL
murine	NULL
myeloid	NULL
leukaemia	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
310:249-251	NULL
.	NULL

17a.Haynes	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
D.	NULL
Wiginton	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

18	NULL
.	NULL

Hernandez	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
delta	NULL
enhancer	NULL
by	NULL
functional	NULL
cooperation	NULL
between	NULL
c-Myb	NULL
and	NULL
core-binding	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:473-483	NULL
.	NULL

19	NULL
.	NULL

Howe	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Watson	NULL
.	NULL

1991	NULL
.	NULL

Nucleotide	NULL
preferences	NULL
in	NULL
sequence-specific	NULL
recognition	NULL
of	NULL
DNA	NULL
by	NULL
c-myb	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:3913-3919	NULL
.	NULL

20	NULL
.	NULL

Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
W.	NULL
C.	NULL
Forrester	NULL
,	NULL
R.	NULL
G.	NULL
Qiu	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
immunoglobulin	NULL
mu	NULL
enhancer	NULL
core	NULL
establishes	NULL
local	NULL
factor	NULL
access	NULL
in	NULL
nuclear	NULL
chromatin	NULL
independent	NULL
of	NULL
transcriptional	NULL
stimulation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2016-2032	NULL
.	NULL

21	NULL
.	NULL

Kanei	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
E.	NULL
M.	NULL
MacMillan	NULL
,	NULL
T.	NULL
Nomura	NULL
,	NULL
A.	NULL
Sarai	NULL
,	NULL
R.	NULL
G.	NULL
Ramsay	NULL
,	NULL
S.	NULL
Aimoto	NULL
,	NULL
S.	NULL
Ishii	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Gonda	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
and	NULL
transformation	NULL
by	NULL
Myb	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
a	NULL
leucine-zipper	NULL
structure	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3088-3092	NULL
.	NULL

22	NULL
.	NULL

Kanei	NULL
,	NULL
I	NULL
C.	NULL
,	NULL
T.	NULL
Yasukawa	NULL
,	NULL
R.	NULL
I.	NULL
Morimoto	NULL
,	NULL
and	NULL
S.	NULL
Ishii	NULL
.	NULL

1994.	NULL
c-Myb-induced	NULL
trans-activation	NULL
mediated	NULL
by	NULL
heat	NULL
shock	NULL
elements	NULL
without	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
c-Myb	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:15768-15775	NULL
.	NULL

23	NULL
.	NULL

Liischer	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Eisenman	NULL
.	NULL

1988.	NULL
c-myc	NULL
and	NULL
c-myb	NULL
protein	NULL
degrada-tion	NULL
:	NULL
effect	NULL
of	NULL
metabolic	NULL
inhibitors	NULL
and	NULL
heat	NULL
shock	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:2504-2512	NULL
.	NULL

24	NULL
.	NULL

McClinton	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Stafford	NULL
,	NULL
L.	NULL
Brents	NULL
,	NULL
T.	NULL
P.	NULL
Bender	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Kuehl	NULL
.	NULL

1990	NULL
.	NULL

Differentiation	NULL
of	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
is	NULL
blocked	NULL
by	NULL
late	NULL
up-regu-lation	NULL
of	NULL
a	NULL
c-myb	NULL
transgene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:705-710	NULL
.	NULL

25	NULL
.	NULL

Miller	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

1972	NULL
.	NULL

Experiments	NULL
in	NULL
molecular	NULL
genetics	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
26	NULL
.	NULL

Mucenski	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
K.	NULL
McLain	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Kier	NULL
,	NULL
S.	NULL
H.	NULL
Swerdlow	NULL
,	NULL
C.	NULL
M.	NULL
Schreiner	NULL
,	NULL
T.	NULL
A.	NULL
Miller	NULL
,	NULL
D.	NULL
W.	NULL
Pictryga	NULL
,	NULL
W.	NULL
J.	NULL
Scott	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Potter	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
functional	NULL
c-myb	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
murine	NULL
fetal	NULL
hepatic	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
65:677-689	NULL
.	NULL

27	NULL
.	NULL

Nicolaides	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
R.	NULL
Gualdi	NULL
,	NULL
C.	NULL
Casadevall	NULL
,	NULL
L.	NULL
Manzella	NULL
,	NULL
and	NULL
B.	NULL
Calabretta	NULL
.	NULL

1991	NULL
.	NULL

Positive	NULL
autoregulation	NULL
of	NULL
c-myb	NULL
expression	NULL
via	NULL
Myb	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
c-myb	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:6166-6176	NULL
.	NULL

28	NULL
.	NULL

Nossal	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

1994	NULL
.	NULL

Negative	NULL
selection	NULL
of	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
76:229-239	NULL
.	NULL

29	NULL
.	NULL

Ogata	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Morikawa	NULL
,	NULL
H.	NULL
Nakamura	NULL
,	NULL
A.	NULL
Sekikawa	NULL
,	NULL
T.	NULL
Inoue	NULL
,	NULL
H.	NULL
Kanai	NULL
,	NULL
A.	NULL
Sarai	NULL
,	NULL
S.	NULL
Ishii	NULL
,	NULL
and	NULL
Y.	NULL
Nishimura	NULL
.	NULL

1994	NULL
.	NULL

Solution	NULL
structure	NULL
of	NULL
a	NULL
specific	NULL
DNA	NULL
complex	NULL
of	NULL
the	NULL
Myb	NULL
DNA-binding	NULL
domain	NULL
with	NULL
cooperative	NULL
recognition	NULL
helices	NULL
.	NULL

Cell	NULL
79:639-648	NULL
.	NULL

30	NULL
.	NULL

Peterson	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
and	NULL
G.	NULL
Stamatoyannopoulos	NULL
.	NULL

1993	NULL
.	NULL

Role	NULL
of	NULL
gene	NULL
order	NULL
in	NULL
developmental	NULL
control	NULL
of	NULL
human	NULL
gamma-	NULL
and	NULL
beta-globin	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4836-4843	NULL
.	NULL

31	NULL
.	NULL

Ratajezak	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
S.	NULL
M.	NULL
Luger	NULL
,	NULL
N.	NULL
Hijiya	NULL
,	NULL
J.	NULL
Zhang	NULL
,	NULL
G.	NULL
Zon	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Gewirtz	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
treatment	NULL
of	NULL
human	NULL
leukemia	NULL
in	NULL
a	NULL
scid	NULL
mouse	NULL
model	NULL
with	NULL
c-myb	NULL
antisense	NULL
oligodeoxynucleotides	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:11823-11827	NULL
.	NULL

32	NULL
.	NULL

Sheiness	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
M.	NULL
Gardinier	NULL
.	NULL

1984	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
proto-oncogene	NULL
(	NULL
proto-myb	NULL
)	NULL
in	NULL
hemopoietic	NULL
tissues	NULL
of	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4:1206-1212	NULL
.	NULL

33	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
L.	NULL
Wurster	NULL
,	NULL
J.	NULL
S.	NULL
Lipsick	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
requires	NULL
a	NULL
Myb	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1592-1604	NULL
.	NULL

34	NULL
.	NULL

Surh	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
Sprent	NULL
.	NULL

1994	NULL
.	NULL

T-cell	NULL
apoptosis	NULL
detected	NULL
in	NULL
situ	NULL
during	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
372:100-103	NULL
.	NULL

35	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
P.	NULL
B.	NULL
Challoner	NULL
,	NULL
P.	NULL
E.	NULL
Neiman	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1986	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
e-myb	NULL
proto-oncogene	NULL
during	NULL
cellular	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
319:374-380	NULL
.	NULL

36	NULL
.	NULL

West	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Jr.	NULL
,	NULL
R.	NULL
R.	NULL
Yocum	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1984	NULL
.	NULL

Saccharomyces	NULL
cerevi-sine	NULL
GALI-GAL1IO	NULL
divergent	NULL
promoter	NULL
region	NULL
:	NULL
location	NULL
and	NULL
function	NULL
of	NULL
the	NULL
upstream	NULL
activating	NULL
sequence	NULL
UASG	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

42467-2478	NULL
.	NULL

37	NULL
.	NULL

Westin	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
K.	NULL
M.	NULL
Gorse	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Clarke	NULL
.	NULL

1990	NULL
.	NULL

Alternative	NULL
splicing	NULL
of	NULL
the	NULL
human	NULL
c-myb	NULL
gene	NULL
.	NULL

Oncogene	NULL
5:1117-1124	NULL
.	NULL

